FORM 10-Q
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
|
|
|
þ |
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended June 30, 2006
OR
|
|
|
o |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934 |
Commission file number: 1-4219
ZAPATA CORPORATION
(Exact name of Registrant as specified in its charter)
|
|
|
State of Nevada
|
|
C-74-1339132 |
(State or other jurisdiction of
|
|
(I.R.S. Employer |
in corporation or organization)
|
|
Identification No.) |
|
|
|
100 Meridian Centre, Suite 350 |
|
|
Rochester, NY
|
|
14618 |
(Address of principal executive
|
|
(Zip Code) |
offices) |
|
|
(585) 242-2000
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by
Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the Registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. Yes þ or No o.
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer,
or a non-accelerated filer. See definitions of accelerated filer and large accelerated filer in
Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer o Accelerated filer þ Non-accelerated filer o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the
Act). Yes o or No þ
As of August 1, 2006, the Registrant had outstanding 19,182,456 shares of common stock, $0.01 par
value.
ZAPATA CORPORATION
TABLE OF CONTENTS
2
PART I FINANCIAL INFORMATION
Item 1. Financial Statements and Notes
ZAPATA CORPORATION
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(In Thousands, Except Per Share Amounts)
|
|
|
|
|
|
|
|
|
|
|
June 30, |
|
|
December 31, |
|
|
|
2006 |
|
|
2005 |
|
ASSETS |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
88,326 |
|
|
$ |
103,373 |
|
Accounts receivable, net |
|
|
27,763 |
|
|
|
24,170 |
|
Inventory |
|
|
58,920 |
|
|
|
46,860 |
|
Prepaid expenses and other current assets |
|
|
4,713 |
|
|
|
2,314 |
|
|
|
|
|
|
|
|
Total current assets |
|
|
179,722 |
|
|
|
176,717 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other assets, net |
|
|
23,101 |
|
|
|
23,652 |
|
Property, plant and equipment, net |
|
|
101,430 |
|
|
|
93,985 |
|
|
|
|
|
|
|
|
Total assets |
|
$ |
304,253 |
|
|
$ |
294,354 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS EQUITY |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Current maturities of long-term debt |
|
$ |
2,386 |
|
|
$ |
2,443 |
|
Accounts payable |
|
|
1,450 |
|
|
|
3,989 |
|
Accrued and other current liabilities |
|
|
26,539 |
|
|
|
15,850 |
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
30,375 |
|
|
|
22,282 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt |
|
|
26,454 |
|
|
|
27,658 |
|
Pension liabilities |
|
|
11,842 |
|
|
|
11,810 |
|
Other liabilities and deferred taxes |
|
|
1,885 |
|
|
|
983 |
|
|
|
|
|
|
|
|
Total liabilities |
|
|
70,556 |
|
|
|
62,733 |
|
|
|
|
|
|
|
|
Minority interest |
|
|
61,692 |
|
|
|
59,937 |
|
Commitments and contingencies |
|
|
|
|
|
|
|
|
Stockholders equity: |
|
|
|
|
|
|
|
|
Preferred stock, $.01 par; 1,600,000 shares
authorized; none issued or outstanding |
|
|
|
|
|
|
|
|
Preference stock, $.01 par; 14,400,000
shares authorized; none issued or
outstanding |
|
|
|
|
|
|
|
|
Common stock, $0.01 par, 132,000,000 shares
authorized; 24,614,536 and 24,581,636 shares
issued; and 19,182,456 and 19,149,556 shares
outstanding, respectively |
|
|
246 |
|
|
|
246 |
|
Capital in excess of par value |
|
|
162,929 |
|
|
|
162,730 |
|
Retained earnings |
|
|
45,254 |
|
|
|
45,127 |
|
Treasury stock, at cost, 5,432,080 shares |
|
|
(31,668 |
) |
|
|
(31,668 |
) |
Accumulated other comprehensive loss |
|
|
(4,756 |
) |
|
|
(4,751 |
) |
|
|
|
|
|
|
|
Total stockholders equity |
|
|
172,005 |
|
|
|
171,684 |
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity |
|
$ |
304,253 |
|
|
$ |
294,354 |
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the condensed consolidated financial statements.
3
ZAPATA CORPORATION
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In Thousands, Except Per Share Amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Six Months Ended |
|
|
|
June 30, |
|
|
June 30, |
|
|
|
2006 |
|
|
2005 |
|
|
2006 |
|
|
2005 |
|
Revenues |
|
$ |
33,338 |
|
|
$ |
27,510 |
|
|
$ |
61,641 |
|
|
$ |
51,341 |
|
Cost of revenues |
|
|
28,002 |
|
|
|
23,693 |
|
|
|
49,313 |
|
|
|
44,468 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
5,336 |
|
|
|
3,817 |
|
|
|
12,328 |
|
|
|
6,873 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expense: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative |
|
|
5,678 |
|
|
|
4,387 |
|
|
|
10,533 |
|
|
|
8,829 |
|
Loss resulting from natural disaster |
|
|
193 |
|
|
|
|
|
|
|
433 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses |
|
|
5,871 |
|
|
|
4,387 |
|
|
|
10,966 |
|
|
|
8,829 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating (loss) income |
|
|
(535 |
) |
|
|
(570 |
) |
|
|
1,362 |
|
|
|
(1,956 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expense): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income |
|
|
1,092 |
|
|
|
388 |
|
|
|
2,159 |
|
|
|
701 |
|
Interest expense |
|
|
(528 |
) |
|
|
(242 |
) |
|
|
(1,052 |
) |
|
|
(508 |
) |
Other, net |
|
|
86 |
|
|
|
247 |
|
|
|
68 |
|
|
|
208 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
650 |
|
|
|
393 |
|
|
|
1,175 |
|
|
|
401 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before income taxes and minority
interest |
|
|
115 |
|
|
|
(177 |
) |
|
|
2,537 |
|
|
|
(1,555 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Provision) benefit for income taxes |
|
|
(209 |
) |
|
|
(28 |
) |
|
|
(1,082 |
) |
|
|
403 |
|
Minority interest in net income of
consolidated subsidiaries |
|
|
(265 |
) |
|
|
(276 |
) |
|
|
(1,328 |
) |
|
|
(319 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income from continuing operations |
|
|
(359 |
) |
|
|
(481 |
) |
|
|
127 |
|
|
|
(1,471 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discontinued operations: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before taxes and minority interest
(including loss on disposal) |
|
|
|
|
|
|
2,639 |
|
|
|
|
|
|
|
5,716 |
|
Provision for income taxes |
|
|
|
|
|
|
(1,269 |
) |
|
|
|
|
|
|
(2,857 |
) |
Minority interest |
|
|
|
|
|
|
(425 |
) |
|
|
|
|
|
|
(846 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income from discontinued operations |
|
|
|
|
|
|
945 |
|
|
|
|
|
|
|
2,013 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income to common stockholders |
|
$ |
(359 |
) |
|
$ |
464 |
|
|
$ |
127 |
|
|
$ |
542 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
(loss) income per common share basic and diluted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income from continuing operations |
|
$ |
(0.02 |
) |
|
$ |
(0.03 |
) |
|
$ |
0.01 |
|
|
$ |
(0.08 |
) |
Discontinued operations, net of income taxes
and minority interest |
|
|
|
|
|
|
0.05 |
|
|
|
|
|
|
|
0.11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income per common share basic and
diluted |
|
$ |
(0.02 |
) |
|
$ |
0.02 |
|
|
$ |
0.01 |
|
|
$ |
0.03 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
19,182 |
|
|
|
19,135 |
|
|
|
19,176 |
|
|
|
19,134 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted |
|
|
19,182 |
|
|
|
19,345 |
|
|
|
19,383 |
|
|
|
19,379 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the condensed consolidated financial statements.
4
ZAPATA CORPORATION
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended |
|
|
|
June 30, |
|
|
|
2006 |
|
|
2005 |
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
Net income |
|
$ |
127 |
|
|
$ |
542 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
|
6,362 |
|
|
|
6,681 |
|
Loss on disposal of assets |
|
|
29 |
|
|
|
96 |
|
Provisions for losses on receivables |
|
|
15 |
|
|
|
15 |
|
Stock option modification expense |
|
|
|
|
|
|
353 |
|
Stock-based compensation |
|
|
73 |
|
|
|
|
|
Minority interest in net income of consolidated subsidiaries |
|
|
1,328 |
|
|
|
319 |
|
Deferred income taxes |
|
|
1,022 |
|
|
|
(713 |
) |
Changes in assets and liabilities: |
|
|
|
|
|
|
|
|
Accounts receivable |
|
|
(5,503 |
) |
|
|
763 |
|
Inventories |
|
|
(12,060 |
) |
|
|
(16,405 |
) |
Prepaid expenses and other current assets |
|
|
(2,397 |
) |
|
|
(615 |
) |
Other assets |
|
|
(716 |
) |
|
|
(389 |
) |
Accounts payable |
|
|
(2,644 |
) |
|
|
(542 |
) |
Pension liabilities |
|
|
32 |
|
|
|
384 |
|
Accrued liabilities and other current liabilities |
|
|
10,689 |
|
|
|
3,787 |
|
Other liabilities |
|
|
807 |
|
|
|
(78 |
) |
Discontinued operations |
|
|
|
|
|
|
5,448 |
|
|
|
|
|
|
|
|
Total adjustments |
|
|
(2,963 |
) |
|
|
(896 |
) |
|
|
|
|
|
|
|
Net cash used in operating activities |
|
|
(2,836 |
) |
|
|
(354 |
) |
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
Proceeds from insurance company hurricane |
|
|
2,000 |
|
|
|
|
|
Proceeds from disposition of assets |
|
|
|
|
|
|
339 |
|
Gain on involuntary conversion |
|
|
|
|
|
|
(307 |
) |
Capital expenditures |
|
|
(13,467 |
) |
|
|
(11,312 |
) |
Discontinued operations |
|
|
|
|
|
|
(4,076 |
) |
|
|
|
|
|
|
|
Net cash used in investing activities |
|
|
(11,467 |
) |
|
|
(15,356 |
) |
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
Principal payments of long-term debt |
|
|
(1,261 |
) |
|
|
(821 |
) |
Proceeds from stock option exercises |
|
|
526 |
|
|
|
539 |
|
Discontinued operations |
|
|
|
|
|
|
(1,363 |
) |
|
|
|
|
|
|
|
Net cash used in financing activities |
|
|
(735 |
) |
|
|
(1,645 |
) |
Effect of exchange rate changes on cash and cash equivalents |
|
|
(9 |
) |
|
|
(2,413 |
) |
|
|
|
|
|
|
|
Net decrease in cash and cash equivalents |
|
|
(15,047 |
) |
|
|
(19,768 |
) |
Decrease in cash from discontinued operations |
|
|
|
|
|
|
403 |
|
Cash and cash equivalents at beginning of period |
|
|
103,373 |
|
|
|
63,249 |
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of period |
|
$ |
88,326 |
|
|
$ |
43,884 |
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of the condensed consolidated financial statements.
5
ZAPATA CORPORATION
NOTES TO UNAUDITED CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS
Note 1. Summary of Operations and Basis of Presentation
The unaudited condensed consolidated financial statements included herein have been
prepared by Zapata Corporation (Zapata or the Company) pursuant to the rules and
regulations of the Securities and Exchange Commission. The financial statements reflect all
adjustments that are, in the opinion of management, necessary for a fair statement of such
information. All such adjustments are of a normal recurring nature. Although Zapata believes
that the disclosures are adequate to make the information presented not misleading, certain
information and footnote disclosures, including a description of significant accounting
policies normally included in financial statements prepared in accordance with accounting
principles generally accepted in the United States of America, have been condensed or omitted
pursuant to such rules and regulations. The year-end condensed balance sheet data was derived
from audited financial statements, but does not include all disclosures required by accounting
principles generally accepted in the United States of America. The interim financial
statements should be read in conjunction with the financial statements and the notes thereto
included in Zapatas 2005 Annual Report on Form 10-K filed with the Securities and Exchange
Commission and with the information presented by Omega Protein Corporation and Zap.Com
Corporation in their 2005 Annual Reports on Form 10-K. The results of operations for the three
month and six month period ended June 30, 2006 are not necessarily indicative of the results
for any subsequent quarter or the entire fiscal year ending December 31, 2006.
Business Description
Zapata Corporation (Zapata or the Company) is a holding company which currently has one
operating company, Omega Protein Corporation (Omega Protein or Omega), in which the Company had
a 58% ownership interest at June 30, 2006. In addition, Zapata owns 98% of Zap.Com Corporation
(Zap.Com), which is a public shell company. In December 2005, Zapata completed the sale of its
77% ownership interest Safety Components International, Inc. (Safety Components or Safety).
Zapata trades on the New York Stock Exchange (NYSE) under the symbol ZAP.
On December 8, 2005, Zapata announced that the Board of Directors had authorized management to seek
a buyer for its 58% ownership interest in Omega Protein. As of the date of this report, no
agreements or understandings have been entered into by the Company relative to Omega Protein.
There can be no assurance, that a satisfactory transaction involving Omega Protein will emerge, the
timing of any such transaction, if any, or whether the transaction will ultimately enhance Zapata
stockholder value or how that value will be realized. Additionally, there can be no assurance that
we will be able to sell our interest in Omega for an amount in excess of our carrying value. Should
we sell our interest in Omega for an amount less than the carrying value at that time, we would
incur a transaction loss, net of tax consequences. Such losses could be significant and could have
a material adverse impact on our financial position, results from operations and cash flows.
Omega Protein produces and markets a variety of products produced from menhaden (a herring-like
species of fish found in commercial quantities in the U.S. coastal waters of the Atlantic Ocean and
Gulf of Mexico), including regular grade and value-added specialty fish meals, crude and refined
fish oils and fish solubles. Omegas fish meal products are primarily used as a protein ingredient
in animal feed for swine, cattle, aquaculture and household pets. Fish oil is utilized for animal
and aquaculture feeds, industrial applications, additives to human food products and as a dietary
supplement. Omegas fish solubles are sold primarily to livestock feed manufacturers, aquaculture
feed manufacturers and for use as an organic fertilizer. Omega Protein trades on the NYSE under
the symbol OME.
Zap.Com is a public shell company which has no business operations other than complying with its
reporting requirements under the Exchange Act. From time to time, Zap.Com considers acquisitions
that would result in it becoming an operating company. Zap.Com may also consider developing a new
business suitable for its situation. Zap.Com trades on the over-the-counter electronic bulletin
board under the symbol ZPCM.
As used throughout this report, Zapata Corporate is defined as Zapata Corporation exclusive of
its majority owned subsidiaries, Omega Protein and Zap.Com, and its former majority owned
subsidiary, Safety Components.
6
Note 2. Significant Accounting Policies
Share-Based Payment
At June 30, 2006, Zapata had two share-based compensation plans and one special share-based
compensation grant. In addition, Omega Protein had one share-based compensation plan and Zap.Com
had one share-based compensation plan. These plans and special grant are described in more detail
in Note 14. Prior to January 1, 2006, Zapata, Omega Protein and Zap.Com accounted for those plans
under the recognition and measurement principles of Accounting Principles Board (APB) Opinion No.
25, Accounting for Stock Issued to Employees and adopted the disclosure-only provisions of
Statement of Financial Accounting Standards (SFAS) No. 123, Accounting for Stock-Based
Compensation and SFAS No. 148, Accounting for Stock-Based Compensation Transition and
Disclosure an Amendment of FASB Statement No. 123. As a result, no stock-based employee
compensation cost related to stock options was reflected in net income (other than compensation
cost related to stock option modifications), as all options granted under those plans had an
exercise price equal to or greater than the market value of the underlying common stock on the
grant date. Accordingly, share-based compensation related to stock options was generally only
included as a pro-forma disclosure in the financial statement footnotes.
Effective January 1, 2006, Zapata, Omega Protein and Zap.Com each adopted SFAS No. 123R,
Share-Based Payment, using the modified prospective application transition method. Under this
transition method, compensation cost in 2006 includes the portion vesting in the period for (1) all
share-based payments granted prior to, but not vested as of January 1, 2006, based on the grant
date fair value estimated in accordance with the original provisions of SFAS No. 123 and (2) all
share-based payments granted subsequent to January 1, 2006, based on the grant date fair value
estimated in accordance with the provisions of FSAS No. 123R. As share-based compensation expense
recognized in the Condensed Consolidated Statement of Operations for the three months and six
months ended June 30, 2006 is based on awards ultimately expected to vest, it has been reduced for
estimated forfeitures. In the Companys pro forma information required under SFAS 123 for the
periods prior to January 1, 2006, the Company accounted for forfeitures as they occurred. Under
the modified prospective application transition method, no cumulative effect of change in
accounting principle charge is required, and results for prior periods have not been restated. See
below for the pro forma disclosures related to the three months and six months ended June 30, 2005.
SFAS No. 123R also requires excess tax benefits be reported as a financing cash inflow rather than
an operating cash inflow.
Had compensation expense for the Companys consolidated stock option grants been recorded based on
fair value at the grant date using the Black-Sholes optionpricing model, the Companys
consolidated pro forma net loss and loss per share (basic and diluted) would have been as follows:
7
|
|
|
|
|
|
|
|
|
|
|
For the Three Months |
|
|
For the Six Months |
|
|
|
Ended June 30, 2005 |
|
|
Ended June 30, 2005 |
|
|
|
(in thousands) |
|
|
(in thousands) |
|
Net loss from continuing operations, as reported |
|
$ |
(481 |
) |
|
$ |
(1,471 |
) |
Add: Total stock-based employee compensation expense
determined under APB No.25, included in reported net
income, net of tax effects: |
|
|
|
|
|
|
219 |
|
Deduct: Total stock-based employee compensation expense
determined under fair value based method for all awards,
net of tax effects: |
|
|
|
|
|
|
|
|
Zapata Corporate |
|
|
(22 |
) |
|
|
(264 |
) |
Omega Protein |
|
|
(536 |
) |
|
|
(618 |
) |
Zap.Com |
|
|
(1 |
) |
|
|
(3 |
) |
|
|
|
|
|
|
|
Pro forma expense |
|
|
(559 |
) |
|
|
(666 |
) |
|
|
|
|
|
|
|
Pro forma net loss from continuing operations |
|
|
(1,040 |
) |
|
|
(2,137 |
) |
|
|
|
|
|
|
|
|
|
Net income from discontinued operations, as reported |
|
|
945 |
|
|
|
2,013 |
|
Deduct: Total stock-based employee compensation expense
determined under fair value based method for all awards,
net of tax effects: |
|
|
|
|
|
|
|
|
Pro forma net income from discontinued operations |
|
|
945 |
|
|
|
2,013 |
|
|
|
|
|
|
|
|
|
Total pro forma net loss |
|
$ |
(95 |
) |
|
$ |
(124 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income per common share basic and diluted as
reported
Loss from continuing operations |
|
$ |
(0.03 |
) |
|
$ |
(0.08 |
) |
Discontinued operations, net of income taxes and minority
interest |
|
|
0.05 |
|
|
|
0.11 |
|
|
|
|
|
|
|
|
Income per common share basic and diluted as reported |
|
$ |
0.02 |
|
|
$ |
0.03 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income per common share basic and diluted pro
forma
Loss from continuing operations |
|
$ |
(0.05 |
) |
|
$ |
(0.11 |
) |
Discontinued operations, net of income taxes and
minority interest |
|
|
0.05 |
|
|
|
0.10 |
|
|
|
|
|
|
|
|
Loss per common share basic and diluted pro forma |
|
$ |
(0.00 |
) |
|
$ |
(0.01 |
) |
|
|
|
|
|
|
|
The condensed consolidated statement of operations for the three months and six month ended June
30, 2006 included $64,000 and $108,000, respectively, of share-based compensation costs are
included in selling, general and administrative expenses. The total income tax benefit recognized
in the income statement for share-based compensation arrangements was $21,000 and $35,000 for the
three months and six months ended June 30, 2006, respectively. As of June 30, 2006 there was
$270,000 of total unrecognized compensation cost related to nonvested share-based compensation that
is expected to be recognized over a weighted average period of 2.4 years. Based on current grants,
total share-based compensation cost for the remainder of fiscal year 2006 is expected to be
$170,000.
Zapata Corporate
Zapata Corporate had no share-based grants in the six months ended June 30, 2006 and the year ended
December 31, 2005. A summary of option activity under the Zapata Corporate Plans as of June 30,
2006, and changes during the six months then ended is presented below:
8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
Average |
|
|
Aggregate |
|
|
|
|
|
|
|
Average |
|
|
Remaining |
|
|
Intrinsic |
|
|
|
|
|
|
|
Exercise |
|
|
Contractual |
|
|
Value |
|
|
|
Shares |
|
|
Price |
|
|
Term |
|
|
(in thousands) |
|
Outstanding at January 1, 2006 |
|
|
1,339,372 |
|
|
$ |
5.56 |
|
|
|
|
|
|
|
|
|
Granted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercised |
|
|
(32,900 |
) |
|
$ |
5.78 |
|
|
|
|
|
|
|
|
|
Forfeited or expired |
|
|
(69,408 |
) |
|
$ |
5.78 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at June 30, 2006 |
|
|
1,237,064 |
|
|
$ |
5.54 |
|
|
2.9 years |
|
$ |
1,799 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at June 30, 2006 |
|
|
1,163,197 |
|
|
$ |
5.45 |
|
|
2.6 years |
|
$ |
1,790 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The total intrinsic value of stock options exercised during the six months ended June 30, 2006
was $11,000.
A summary of the status of Zapata Corporates nonvested shares as of June 30, 2006 and changes
during the six months ended June 30, 2006, is presented below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-Average |
|
|
|
Shares |
|
|
Grant-Date |
|
Nonvested Shares |
|
(in thousands) |
|
|
Fair Value |
|
Nonvested at January 1, 2006 |
|
|
73,867 |
|
|
$ |
1.93 |
|
Granted |
|
|
|
|
|
|
|
|
Vested |
|
|
|
|
|
|
|
|
Forfeited |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nonvested at June 30, 2006 |
|
|
73,867 |
|
|
$ |
1.93 |
|
|
|
|
|
|
|
|
|
As of June 30, 2006, there was $60,000 of total unrecognized compensation cost related to nonvested
share-based compensation arrangements granted under the Zapata Corporate Plans. That cost is
expected to be recognized over a weighted average period of 0.6 years. No shares vested during
the six months ended June 30, 2006. Based on current grants, total share-based compensation cost
for the remainder of fiscal year 2006 is expected to be $57,000.
Omega Protein
On February 27, 2006, Omega granted new options to an employee under its 2000 Long-Term Incentive
Plan for the purchase of 10,000 shares of common stock at an exercise price of $6.27 per share,
which vest in equal one-third portions on 2007, 2008 and 2009. On May 18, 2006, Omega granted new
options to an employee under its 2000 Long-Term for the purchase of 7,500 shares of common stock at
an exercise price of $5.93 per share, which vest in equal one-third portions on 2007, 2008, and
2009.
On April 13, 2006 the Omega Protein Board of Directors approved the establishment of the Omega
Protein Corporation 2006 Incentive Plan which was approved by Omegas stockholders and became
effective on June 7, 2006. On that date options were granted Omegas four independent Directors
for the purchase of an aggregate of 40,000 shares of common stock at an exercise price of $5.76 per
share, which vest in six months and one day from the date of issuance. These were the only options
granted during the six months ended June 30, 2006, under the 2006 Incentive Plan.
There were
79,167 stock option exercises during the six months ended June 30, 2006. A summary
of option activity under the plans for the six months ended June 30, 2006 is as follows:
9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
Average |
|
|
Aggregate |
|
|
|
|
|
|
|
Average |
|
|
Remaining |
|
|
Intrinsic |
|
|
|
|
|
|
|
Exercise |
|
|
Contractual |
|
|
Value |
|
|
|
Shares |
|
|
Price |
|
|
Term |
|
|
(in thousands) |
|
Outstanding at January 1, 2006 |
|
|
4,748,852 |
|
|
$ |
7.35 |
|
|
|
|
|
|
|
|
|
Granted |
|
|
57,500 |
|
|
$ |
5.87 |
|
|
|
|
|
|
|
|
|
Exercised |
|
|
(79,167 |
) |
|
$ |
3.43 |
|
|
|
|
|
|
|
|
|
Forfeited or expired |
|
|
(3,333 |
) |
|
$ |
5.03 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at June 30, 2006 |
|
|
4,723,852 |
|
|
$ |
7.40 |
|
|
|
4.3 |
|
|
$ |
6,920 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at June 30, 2006 |
|
|
4,654,352 |
|
|
$ |
7.43 |
|
|
|
|
|
|
$ |
6,919 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
A summary of the status of Omegas nonvested shares as of June 30, 2006 and changes during the six
months ended June 30, 2006, is presented below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-Average |
|
|
|
Shares |
|
|
Grant-Date |
|
Nonvested Shares |
|
(in thousands) |
|
|
Fair Value |
|
Nonvested at January 1, 2006 |
|
|
18,000 |
|
|
$ |
4.66 |
|
Granted |
|
|
57,500 |
|
|
$ |
2.77 |
|
Vested |
|
|
(2,667 |
) |
|
$ |
3.17 |
|
Forfeited |
|
|
(3,333 |
) |
|
$ |
3.04 |
|
|
|
|
|
|
|
|
|
Nonvested at June 30, 2006 |
|
|
69,500 |
|
|
$ |
2.86 |
|
|
|
|
|
|
|
|
|
As of June 30, 2006, there was $192,000 of total unrecognized compensation cost related to
nonvested share-based compensation arrangements granted under the Omega Plan. That cost is
expected to be recognized over a weighted-average period of 3 years. Based on current grants,
Omegas total share-based compensation cost for the remainder of fiscal year 2006 is expected to be
approximately $106,000.
For current year grants, the fair value of Omegas stock options is equal to the estimated present
value at grant date using the Black-Scholes option pricing model with the following weighted
average assumptions for the stock options granted during the six months ended June 30, 2006:
expected dividend yield of 0 percent; expected volatility of 46.96% percent; risk-free interest
rate of 4.91 percent; and an expected term of 5 years. The expected dividend yield is based on
Omegas annual dividend payout at grant date. Expected volatility is based on the historical
volatility of Omegas stock for a period approximating the expected life. The risk-free interest
rate is based on the U.S. treasury yield in effect at the time of grant and has a term equal to the
expected life. The expected term of the options represents the period of time the options are
expected to be outstanding.
In May 2005, Omega accelerated the vesting of all unvested, out-of-the-money, explicit service
period stock options granted under Omegas 2000 Long-Term Incentive Plan. The purpose of
accelerating vesting was to eliminate future compensation expense that Omega would otherwise
recognize in its Statement of Operations with respect to these accelerated stock options upon the
adoption by Omega of SFAS No. 123R. A stock option was considered out-of-the-money if the stock
option exercise price was greater than $6.04, which was the closing price of Omegas common stock
on the New York Stock Exchange on May 5, 2005. As a result of this action, stock options to
purchase 390,000 shares of Omegas common stock became immediately exercisable. The vesting
created a modification of stock options; however, there was no impact on the fair value of the
options. The weighted average exercise price of all the accelerated stock options was $9.98.
Zap.Com
Zap.Com had no share-based grants in the six months ended June 30, 2006 and the year ended
December 31, 2005. A summary of option activity under the Zap.Com Plan as of June 30, 2006, and
changes during the six months then ended is presented below:
10
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
|
|
|
|
|
|
|
|
Weighted |
|
|
Average |
|
|
Aggregate |
|
|
|
|
|
|
|
Average |
|
|
Remaining |
|
|
Intrinsic |
|
|
|
|
|
|
|
Exercise |
|
|
Contractual |
|
|
Value |
|
|
|
Shares |
|
|
Price |
|
|
Term |
|
|
(in thousands) |
|
Outstanding at January 1, 2006 |
|
|
511,300 |
|
|
$ |
0.08 |
|
|
|
|
|
|
|
|
|
Granted |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercised |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Forfeited or expired |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at June 30, 2006 |
|
|
511,300 |
|
|
$ |
0.08 |
|
|
|
3.3 |
|
|
$ |
79 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at June 30, 2006 |
|
|
170,431 |
|
|
$ |
0.08 |
|
|
|
3.3 |
|
|
$ |
26 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No Zap.Com options were exercised during the six months ended June 30, 2006.
A summary of the status of Zap.Coms nonvested shares as of June 30, 2006 and changes during the
six months ended June 30, 2006, is presented below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-Average |
|
|
Shares |
|
Grant-Date |
Nonvested Shares |
|
(in thousands) |
|
Fair Value |
Nonvested at January 1, 2006 |
|
|
340,869 |
|
|
$ |
0.08 |
|
Granted |
|
|
|
|
|
|
|
|
Vested |
|
|
|
|
|
|
|
|
Forfeited |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nonvested at June 30, 2006 |
|
|
340,869 |
|
|
$ |
0.08 |
|
|
|
|
|
|
|
|
|
|
As of June 30, 2006, there was $18,000 of total unrecognized compensation cost related to nonvested
share-based compensation arrangements granted under the Zap.Com Plan. That cost is expected to be
recognized over a weighted average period of 1.3 years. No shares vested during the three months
ended June 30, 2006. Based on current outstanding grants, Zap.Coms total share-based compensation
cost for the remainder of fiscal year 2006 is expected to be $7,000.
Reclassification
Certain reclassifications of prior information have been made to conform to the current
presentation.
Note 3. Discontinued Operations
Safety Components
Safety Components International, Inc. (Safety Components or Safety) is an independent supplier
of automotive airbag fabric and cushions and technical fabrics with operations in North America and
Europe. Zapata originally purchased its majority interest in Safety in 2003 and accounted for the
transaction under the purchase method of accounting. In the third quarter of 2005, Zapatas Board
of Directors approved a plan to pursue a sale of all of the Companys shares of Safety common
stock. Based on this approval, the Company determined that this subsidiary substantially met the
criteria to report the pending sale as Assets Held for Sale and the subsidiary as Discontinued
Operations in accordance with accounting rules. As used throughout this document, all amounts and
disclosures related to Safety pertain to Discontinued Operations. Zapata closed on the sale of
Safety in December 2005.
11
Operating results of the Companys discontinued operations are described below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended |
|
For the Six Months Ended |
|
|
June 30, |
|
June 30, |
|
|
2006 |
|
2005 |
|
2006 |
|
2005 |
|
|
(unaudited) |
|
(unaudited) |
|
(unaudited) |
|
(unaudited) |
|
|
(in thousands) |
Revenue from discontinued
operations |
|
$ |
|
|
|
$ |
59,008 |
|
|
$ |
|
|
|
$ |
117,620 |
|
Income before taxes and minority
interest |
|
|
|
|
|
|
2,639 |
|
|
|
|
|
|
|
5,716 |
|
Note 4. Inventories
Inventories are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
June 30, 2006 |
|
|
December 31, 2005 |
|
|
|
(in thousands) |
|
Fish meal |
|
$ |
16,360 |
|
|
$ |
14,742 |
|
Fish oil |
|
|
13,795 |
|
|
|
21,552 |
|
Fish solubles |
|
|
533 |
|
|
|
672 |
|
Unallocated inventory cost
pool (including off season
costs) |
|
|
22,567 |
|
|
|
5,926 |
|
Other materials and supplies |
|
|
5,665 |
|
|
|
3,968 |
|
|
|
|
|
|
|
|
Total consolidated inventory |
|
$ |
58,920 |
|
|
$ |
46,860 |
|
|
|
|
|
|
|
|
Omega Proteins inventory at June 30, 2006 and December 31, 2005 is stated at the lower of cost or
market. The elements of unallocated inventory cost pool include plant and vessel related labor,
utilities, rent, repairs and depreciation, to be allocated to inventories produced through the
remainder of 2006.
Note 5. Debt
Long-term debt consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
June 30, 2006 |
|
|
December 31, 2005 |
|
|
|
(in thousands) |
|
U.S. Government guaranteed obligations (Title XI loan)
collateralized
by a first lien on certain vessels and certain plant assets: |
|
|
|
|
|
|
|
|
Amounts due in installments through 2016, interest from 6.5%
to 7.6% |
|
$ |
28,492 |
|
|
$ |
29,737 |
|
Amounts due in installments through 2014, interest at
Eurodollar rates of 5.4% and 4.5% at June 30, 2006 and
December 31, 2005, respectively, plus 4.5% |
|
|
348 |
|
|
|
359 |
|
Other debt at 6.3% to 7.9% at June 30, 2006 and December 31,
2005, respectively |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
Total Omega Proteins debt |
|
|
28,840 |
|
|
|
30,101 |
|
Less: current maturities |
|
|
(2,386 |
) |
|
|
(2,443 |
) |
|
|
|
|
|
|
|
Total consolidated long-term debt |
|
$ |
26,454 |
|
|
$ |
27,658 |
|
|
|
|
|
|
|
|
The Title XI loans are secured by liens on certain of Omegas fishing vessels and mortgages on
Omegas Reedville, Virginia and Abbeville, Louisiana plants. Loans are now available under similar
terms pursuant to the Title XI program without intervening lenders.
In September 2004, the United States Department of Commerce Fisheries Finance Program (the FFP)
approved Omegas financing application in an amount not to exceed $14 million (the Approval
Letter). Borrowings under the Approval Letter are to be used to finance and/or refinance
approximately 73% of the actual depreciable cost of Omegas future fishing vessels refurbishments
and capital expenditures relating to shore-side fishing assets, for a term not to exceed 15 years
from inception at interest rates determined by the U.S. Treasury. Final approval for all such
future projects requires individual approval through the Secretary of Commerce, National Oceanic
and
12
Atmospheric Administration, and National Marine Fisheries Service (National Marine Fisheries
Service). Borrowings under the FFP are required to be evidenced by security agreements,
undertakings, and other documents deemed in the sole discretion of the National Marine Fisheries
Service as necessary to accomplish the intent and purpose of the Approval Letter. Omega is
required to comply with customary National Marine Fisheries Service covenants as well as certain
special covenants. In December 2004, Omega submitted a $4.9 million financing request against the
$14 million approval, and subsequently amended that request to include the entire $14 million.
Omega closed on the $14 million FFP loan on October 17, 2005.
On December 1, 2005, pursuant to the Title XI program, the United States Department of Commerce
approved a second financing application made by Omega in the amount of $16.4 million (the Second
Approval Letter). In May 2006, Omega submitted a $7.8 million financing request under the Second
Approval Letter. As of June 30, 2006, Omega had no borrowings outstanding under the Second
Approval Letter.
Omega has a $20 million revolving credit agreement with Bank of America, N.A. (the Credit
Facility). Borrowings under this facility may be used for working capital and capital
expenditures. The Credit Facility permits Omega to borrow up to $31 million of Title XI loans. The
term of the Credit Facility expires on October 31, 2007, the maximum borrowing availability tied to
Omegas eligible inventory is $10 million and Omega may not generate a net loss for any two
consecutive quarters. The Credit Facility requires that Omega maintain a Fixed Charge Coverage
Ratio of 1.25 to 1, as measured on a quarterly basis using the consolidated results of the four
fiscal quarter period ending with the applicable reporting period. A commitment fee of 37.5 basis
points per annum is payable quarterly on the actual daily amount of the availability under the
Credit Facility. The applicable interest rate will be adjusted (up or down) prospectively on a
quarterly basis from LIBOR plus 2.00% to LIBOR plus 2.50% or at Omegas option, Prime minus 0.50%
to Prime plus 0.00%, depending upon the Fixed Charge Coverage Ratio being greater than 2.5 times to
less than or equal to 1.5 times, respectively. The Credit Facility is collateralized by all of
Omegas trade receivables, inventory and equipment. In addition, the Credit Facility does not
allow for the payment of cash dividends or stock repurchases.
As of June 30, 2006, Omega was out of compliance with the Ratio of Earnings to Fixed Charges
covenant in the Credit Facility. Omega notified the lender of the covenant non-compliance and
received a waiver from the lender.
As of June 30, 2006, Omega had no borrowings outstanding under the Credit Facility. At June 30,
2006 and December 31, 2005, Omega had outstanding letters of credit under the Credit Facility
totaling approximately $3.1 million and $8.0 million, respectively, issued in support of workers
compensation insurance programs as of June 30, 2006 and December 31, 2005 and to purchase fish meal
from a third party as of December 31, 2005.
Note 6. Accrued and Other Current Liabilities
Accrued and other current liabilities are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
June 30, 2006 |
|
|
December 31, 2005 |
|
|
|
(in thousands) |
|
Salary and benefits |
|
$ |
5,851 |
|
|
$ |
4,318 |
|
Insurance |
|
|
4,610 |
|
|
|
4,803 |
|
Trade creditors |
|
|
12,408 |
|
|
|
3,243 |
|
Federal and state income taxes |
|
|
1,872 |
|
|
|
1,844 |
|
Litigation reserves |
|
|
410 |
|
|
|
410 |
|
Other |
|
|
1,388 |
|
|
|
1,232 |
|
|
|
|
|
|
|
|
|
|
$ |
26,539 |
|
|
$ |
15,850 |
|
|
|
|
|
|
|
|
13
Note 7. Earnings Per Share Information
The following table details the potential common shares excluded from the calculation of diluted
earnings per share because the effect would be antidilutive to the net loss for the period or
because the assumed proceeds were greater than the average market price for the period (in
thousands, except per share amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended |
|
For the Six Months Ended |
|
|
June 30, |
|
June 30, |
|
|
2006 |
|
2005 |
|
2006 |
|
2005 |
Potential common shares excluded
from the calculation of diluted earnings
per share: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock options (in thousands) |
|
|
1,237 |
|
|
|
18 |
|
|
|
228 |
|
|
|
12 |
|
Weighted average exercise price per share |
|
$ |
5.54 |
|
|
$ |
9.79 |
|
|
$ |
7.05 |
|
|
$ |
10.94 |
|
Note 8. Comprehensive Income
The components of other comprehensive income (loss) are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended |
|
|
For the Six Months Ended |
|
|
|
June 30, |
|
|
June 30, |
|
|
|
2006 |
|
|
2005 |
|
|
2006 |
|
|
2005 |
|
|
|
(unaudited) |
|
|
(unaudited) |
|
|
(unaudited) |
|
|
(unaudited) |
|
|
|
(in thousands) |
|
Net loss (income) to common stockholders |
|
$ |
(359 |
) |
|
$ |
464 |
|
|
$ |
127 |
|
|
$ |
542 |
|
Currency translation adjustment, net of tax
effects |
|
|
3 |
|
|
|
(8 |
) |
|
|
5 |
|
|
|
(7 |
) |
Amounts related to discontinued operations,
net
of tax effects |
|
|
|
|
|
|
2,292 |
|
|
|
|
|
|
|
3,912 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive (loss) income |
|
$ |
(356 |
) |
|
$ |
2,748 |
|
|
$ |
132 |
|
|
$ |
4,447 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note 9. Commitments and Contingencies
Litigation
In 2004, two of the Companys predecessor subsidiaries were named as defendants in fourteen
lawsuits filed in the Circuit Courts of Jones and Smith Counties in Mississippi. These fourteen
lawsuits included approximately 583 individual plaintiffs, all alleging that they had suffered
various illnesses from exposure to asbestos and seeking damages. The lawsuits assert claims of
unseaworthiness, negligence, and strict liability, primarily based upon the status of the Companys
predecessors as Jones Act employers. These cases include numerous defendants and, in general, the
defendants are all alleged to have been the Jones Act employers of these plaintiffs and/or
manufactured, distributed or utilized products containing asbestos.
Since these lawsuits involved multiple plaintiffs suing multiple defendants, the plaintiffs were
ordered to prepare data sheets specifying the companies they were employed by and the
asbestos-containing products to which they were allegedly exposed. Through this process,
approximately 31 plaintiffs have identified the Company and/or its predecessor subsidiaries as
their employer. Once the data sheet process is complete, we expect that the Company will be
dismissed from any case where it is not identified as the employer. Only minimal medical
information regarding the alleged asbestos-related disease suffered by the plaintiffs has been
provided. Accordingly, the Company is unable to estimate its potential exposure to these lawsuits.
The Company and predecessor subsidiaries maintained insurance which it believes will be available
to respond to the majority of these claims. The Company intends to defend itself vigorously in all
of these cases and, based on the information available to the Company at this time, the Company
does not expect the outcome of these lawsuits to have a material adverse effect on its financial
position, results of operations or cash flows; however, there can be no assurance as to the
ultimate outcome of these lawsuits or additional similar lawsuits, if any, that may be filed.
Zapata is involved in litigation relating to claims arising out of its past and current operations
in the normal course of business. Zapata maintains insurance coverage against such potential
ordinary course claims in an amount in which it believes to be adequate. While the results of any
ultimate resolution cannot be predicted, in the opinion of
14
Zapatas management, based upon discussions with counsel, any losses resulting from these matters
will not have a material adverse effect on Zapatas results of consolidated operations, cash flow
or financial position.
Environmental Matters
During the third quarter of 2005, Zapata was notified by Weatherford International Inc.
(Weatherford) of a claim for reimbursement of approximately $200,000 in connection with the
investigation and cleanup of purported environmental contamination at two properties formerly owned
by a non-operating Zapata subsidiary. The claim was made under an indemnification provision given
by Zapata to Weatherford in a 1995 asset purchase agreement and relates to alleged environmental
contamination that purportedly existed on the properties prior to the date of the sale.
Weatherford has also advised the Company that it anticipates that further remediation and cleanup
may be required, although they have not provided any information regarding the cost of any such
future clean up.
Based upon the initial review of the environmental expert that the Company retained, the Company
wrote to Weatherfords counsel on May 30, 2006. In this letter, the Company challenged any
responsibility to indemnify Weatherford based in part on the possibility that Weatherford either a)
failed to mitigate any existing on-site conditions post-closing or b) exacerbated any existing
on-site conditions post-closing.
Given the above, while it is reasonably possible that some costs may be incurred related to this
site, the Company presently has inadequate information to enable it to estimate any reasonably
possible range of estimated liability relating to these sites beyond the specific amount claimed to
date by Weatherford. Further, there can be no assurance that the Company will not incur material
costs and expenses in connection with any further investigation and remediation at the site.
Zapata and its subsidiaries are subject to various possible claims and lawsuits regarding
environmental matters in addition to those discussed above. Zapatas management believes that
costs, if any, related to these matters will not have a material adverse effect on the consolidated
results of operations, cash flows or financial position of the Company.
Guarantees
The Company has applied the disclosure provisions of FASB Interpretation No. 45 (FIN 45),
Guarantors Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees
of Indebtedness of Others, to its agreements containing guarantee or indemnification clauses.
These disclosure provisions expand those required by SFAS No. 5, Accounting for Contingencies, by
requiring a guarantor to disclose certain types of guarantees, even if the likelihood of requiring
the guarantors performance is remote. The following is a description of arrangements in which the
Company is the guarantor.
Throughout its history, the Company has entered into numerous transactions relating to the sale,
disposal or spin-off of past operations. Pursuant to certain of these transactions, the Company
may be obligated to indemnify other parties to these agreements. These obligations include
indemnifications for losses incurred by such parties arising out of the operations of such
businesses prior to these transactions or the inaccuracy of representations of information supplied
by the Company in connection with such transactions. These indemnification obligations were in
effect prior to December 31, 2002 and are therefore grandfathered under the provisions of FIN No.
45. Accordingly, no liabilities have been recorded for the indemnification clauses in these
agreements.
Note 10. Related Party Transactions
Zap.Com Corporation
Since its inception, Zap.Com has utilized the services of the Zapatas management and staff under a
shared services agreement that allocated these costs on a percentage of time basis. Zap.Com also
subleases its office space in Rochester, New York from Zapata. Under the sublease agreement,
annual rental payments are allocated on a cost basis. Zapata has waived its rights under the
shared services agreement to be reimbursed for these expenses since May 1, 2000. For each of the
three months and six months ended June 30, 2006 and 2005, approximately $3,000 and $6,000,
respectively, was recorded as contributed capital for these services.
15
Other
In February 2005, the Company modified the terms of certain outstanding stock options held by
Darcie Glazer and Edward Glazer, to extend the early termination of the exercise period following
Darcie Glazers termination of employment with the Company in 2001. Consistent with FASB
Interpretation No. 44, Accounting for Certain Transactions involving Stock Compensation (an
interpretation of APB Opinion No. 25), the Company recorded a compensation charge of approximately
$353,000 related to this modification during the first quarter of 2005.
During 2002, the Company finalized the terms of a consulting agreement with its former Chairman of
the Board of Directors, Malcolm Glazer. Subject to the terms of the agreement, the Company paid
Malcolm Glazer $122,500 per month until April 30, 2006. The agreement also provided for health and
medical benefits for Mr. Glazer and his wife. Subsequent to the termination of the agreement on
April 30, 2006, the Company has continued to provide health and medical benefits for Mr. Glazer and
his wife under the Companys Senior Executive Retiree Health Care Benefit Plan. These health
insurance benefits are consistent with Zapatas existing benefits available to employees. During
the second quarter of 2006, the Company recorded $831,000 in selling, general and administrative
expenses to reflect the total estimated liability for Mr. Glazers participation in this plan.
Note 11. Recently Issued Accounting Pronouncements
In June 2006, the FASB issued FASB Interpretation No. 48, Accounting for Uncertainty in Income
Taxes. The interpretation clarifies the accounting for uncertainty in income taxes recognized in a
companys financial statements in accordance with Statement of Financial Accounting Standards No.
109, Accounting for Income Taxes. Specifically, the pronouncement prescribes a recognition
threshold and a measurement attribute for the financial statement recognition and measurement of a
tax position taken or expected to be taken in a tax return. The interpretation also provides
guidance on the related derecognition, classification, interest and penalties, accounting for
interim periods, disclosure and transition of uncertain tax positions. The interpretation is
effective for fiscal years beginning after December 15, 2006. The Company is currently evaluating
the impact, if any, of this new pronouncement on its consolidated financial statements.
Note 12. Qualified Defined Benefit Plans
Zapata and Omega Protein have separate and independent noncontributory defined benefit plans
covering certain U.S. employees. Both Zapata and Omegas defined benefit pension plans were frozen
as of June 30, 2006. Additionally, Zapata has a supplemental pension plan, which provides
supplemental retirement payments to certain former senior executives of Zapata.
The amounts shown below reflect the consolidated defined benefit pension plan expense for Zapata
and Omega Protein, including Zapatas supplemental pension plan expense.
Components of Net Periodic Benefit Cost
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended |
|
|
For the Six Months Ended |
|
|
|
June 30, |
|
|
June 30, |
|
|
|
2006 |
|
|
2005 |
|
|
2006 |
|
|
2005 |
|
|
|
(unaudited) |
|
|
(unaudited) |
|
|
(unaudited) |
|
|
(unaudited) |
|
|
|
(in thousands) |
|
Service cost |
|
$ |
13 |
|
|
$ |
10 |
|
|
$ |
26 |
|
|
$ |
21 |
|
Interest cost |
|
|
629 |
|
|
|
645 |
|
|
|
1,258 |
|
|
|
1,291 |
|
Expected return on plan assets |
|
|
(714 |
) |
|
|
(734 |
) |
|
|
(1,428 |
) |
|
|
(1,468 |
) |
Amortization of transition assets and other
deferrals |
|
|
428 |
|
|
|
375 |
|
|
|
856 |
|
|
|
751 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net periodic benefit cost |
|
$ |
356 |
|
|
$ |
296 |
|
|
$ |
712 |
|
|
$ |
595 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Zapatas defined benefit pension plan was frozen on January 15, 2006. In accordance with ERISA
rules and regulations, new employees after that date will not be able to participate in the pension
plan and further benefits will no longer accrue for existing participants. Additionally, the
freezing of the plan caused the Company to recognize a curtailment loss of approximately $147,000
during the first quarter of 2006, which represents the balance of the
16
unamortized prior service cost. Zapata plans to make no contributions to its pension plan or to its
supplemental pension plan in 2006.
Omegas defined benefit pension plan was frozen on July 31, 2002. As of June 30, 2006, Omega had
made contributions to the pension plan totaling $432,000. Omega expects to make contributions of
$2.2 million to the pension plan during the remainder of 2006. No contributions to Omegas pension
plan were made during fiscal 2005.
Note 13. Hurricane Losses
On August 29, 2005, Omegas Moss Point, Mississippi fish processing facility and adjacent shipyard
were severely damaged by Hurricane Katrina. On September 24, 2005, Omegas Cameron, Louisiana and
the Abbeville, Louisiana fish processing facilities were also severely damaged by Hurricane Rita.
For the three month and six month periods ended June 30, 2006, $192,000 and $433,000 of additional
clean-up costs were recognized.
In order to facilitate the insurance recovery process, on July 28, 2006, Omega filed a lawsuit
against its property insurance carriers, Lexington Insurance Company and RSUI Indemnity Company, in
U.S. District Court for the Western District of Louisiana, alleging breach of contract and bad
faith based on the insurance carriers failure to pay amounts due to the Company under its property
insurance policies for damages sustained from Hurricanes Katrina and Rita in the third quarter of
2005. The Company seeks recovery in a jury trial of all available damages to which it is entitled
by law, legal interest on those damages, the cost of the litigation and any other damages as the
court deems appropriate.
The total damages sought in the lawsuit are in excess of the amount Omega has remaining as a receivable relating
to its initial recorded hurricane claim from its property insurance carriers. Omega believes collection of
the recorded receivable is probable; however, an unfavorable outcome of the proceeding could have a
material impact on Omegas financial position and result of operations.
Note 14. Industry Segment and Geographic Information
The following summarizes certain financial information of each segment for the three months ended
June 30, 2006 and 2005:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest |
|
|
Income |
|
|
|
|
|
|
|
|
|
|
Operating |
|
|
|
|
|
|
Depreciation |
|
|
(Expense) |
|
|
Tax |
|
|
|
|
|
|
|
|
|
|
Income |
|
|
Total |
|
|
and |
|
|
Income, |
|
|
(Provision) |
|
|
Capital |
|
|
|
Revenues |
|
|
(Loss) |
|
|
Assets |
|
|
Amortization |
|
|
net |
|
|
Benefit |
|
|
Expenditures |
|
Three Months Ended
June 30, 2006 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Zap.Com |
|
$ |
|
|
|
$ |
(44 |
) |
|
$ |
1,744 |
|
|
$ |
|
|
|
$ |
21 |
|
|
$ |
|
|
|
$ |
|
|
Corporate |
|
|
|
|
|
|
(1,964 |
) |
|
|
91,614 |
|
|
|
4 |
|
|
|
896 |
|
|
|
177 |
|
|
|
|
|
Omega Protein |
|
|
33,338 |
|
|
|
1,473 |
|
|
|
210,895 |
|
|
|
2,950 |
|
|
|
(353 |
) |
|
|
(386 |
) |
|
|
6,932 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
33,338 |
|
|
$ |
(535 |
) |
|
$ |
304,253 |
|
|
$ |
2,954 |
|
|
$ |
564 |
|
|
$ |
(209 |
) |
|
$ |
6,932 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
June 30, 2005 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Zap.Com |
|
$ |
|
|
|
$ |
(35 |
) |
|
$ |
1,782 |
|
|
$ |
1 |
|
|
$ |
12 |
|
|
$ |
|
|
|
$ |
|
|
Corporate |
|
|
|
|
|
|
(1,299 |
) |
|
|
44,714 |
|
|
|
8 |
|
|
|
186 |
|
|
|
255 |
|
|
|
|
|
Omega Protein |
|
|
27,510 |
|
|
|
764 |
|
|
|
194,186 |
|
|
|
3,331 |
|
|
|
(52 |
) |
|
|
(283 |
) |
|
|
5,545 |
|
Discontinued
Operations |
|
|
|
|
|
|
|
|
|
|
118,166 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
27,510 |
|
|
$ |
(570 |
) |
|
$ |
358,848 |
|
|
$ |
3,340 |
|
|
$ |
146 |
|
|
$ |
(28 |
) |
|
$ |
5,545 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
17
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest |
|
|
Income |
|
|
|
|
|
|
|
|
|
|
Operating |
|
|
|
|
|
|
Depreciation |
|
|
(Expense) |
|
|
Tax |
|
|
|
|
|
|
|
|
|
|
Income |
|
|
Total |
|
|
and |
|
|
Income, |
|
|
(Provision) |
|
|
Capital |
|
|
|
Revenues |
|
|
(Loss) |
|
|
Assets |
|
|
Amortization |
|
|
net |
|
|
Benefit |
|
|
Expenditures |
|
Six Months Ended
June 30, 2006 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Zap.Com |
|
$ |
|
|
|
$ |
(74 |
) |
|
$ |
1,744 |
|
|
$ |
|
|
|
$ |
40 |
|
|
$ |
|
|
|
$ |
|
|
Corporate |
|
|
|
|
|
|
(3,453 |
) |
|
|
91,614 |
|
|
|
10 |
|
|
|
1,712 |
|
|
|
(120 |
) |
|
|
|
|
Omega Protein |
|
|
61,641 |
|
|
|
4,889 |
|
|
|
210,895 |
|
|
|
6,352 |
|
|
|
(645 |
) |
|
|
(962 |
) |
|
|
13,467 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
61,641 |
|
|
$ |
1,362 |
|
|
$ |
304,253 |
|
|
$ |
6,362 |
|
|
$ |
1,107 |
|
|
$ |
(1,082 |
) |
|
$ |
13,467 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended
June 30, 2005 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Zap.Com |
|
$ |
|
|
|
$ |
(65 |
) |
|
$ |
1,782 |
|
|
$ |
1 |
|
|
$ |
22 |
|
|
$ |
|
|
|
$ |
|
|
Corporate |
|
|
|
|
|
|
(2,933 |
) |
|
|
44,714 |
|
|
|
19 |
|
|
|
346 |
|
|
|
695 |
|
|
|
|
|
Omega Protein |
|
|
51,341 |
|
|
|
1,042 |
|
|
|
194,186 |
|
|
|
6,661 |
|
|
|
(175 |
) |
|
|
(292 |
) |
|
|
11,312 |
|
Discontinued
Operations |
|
|
|
|
|
|
|
|
|
|
118,166 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
51,341 |
|
|
$ |
(1,956 |
) |
|
$ |
358,848 |
|
|
$ |
6,681 |
|
|
$ |
193 |
|
|
$ |
403 |
|
|
$ |
11,312 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note 15. Stock Option Plans
Zapata Corporate
Zapatas Amended and Restated Special Incentive Plan (the 1987 Plan), which was stockholder
approved, provides for the granting of stock options and the awarding of restricted stock. Under
the 1987 Plan, options may be granted at prices equivalent to the market value of the common stock
at the date of grant. Options become exercisable on dates as determined by the Zapata Board of
Directors Compensation Committee, provided that the earliest such date cannot occur before six
months after the date of grant. Unexercised options will expire on varying dates, up to a maximum
of ten years from the date of grant. All options granted vest ratably over three years beginning on
the first anniversary of the date of grant and have an exercise price equal to the fair market
value of the stock at grant date. The 1987 Plan provided for the issuance of up to 480,000 shares
of the common stock. During 1992, the stockholders approved an amendment to the 1987 Plan that
provided for the automatic grant of a nonqualified stock option to directors of Zapata who are not
employees of Zapata or any subsidiary of Zapata.
On December 5, 1996, the Companys stockholders approved a long-term incentive plan (the 1996
Plan). The 1996 Plan provides for the granting of restricted stock, stock appreciation rights,
stock options and other types of awards to key employees of the Company. Under the 1996 Plan,
options may be granted by the Committee at prices equivalent to the market value of the common
stock on the date of grant. Options become exercisable in one or more installments on such dates as
the Committee may determine. Unexercised options will expire on varying dates up to a maximum of
ten years from the date of grant. All options granted vest ratably over three years beginning on
the first anniversary of the date of grant and have an exercise price equal to the fair market
value of the stock at grant date. The 1996 Plan provides for the issuance of options to purchase
up to 8.0 million shares of common stock.
In May 2002, the Stockholders approved a special share-based compensation grant of 8,000 stock
options to each of the six non-employee directors of the Company. These grants had been approved
by the Board of Directors and awarded by the Company in March of 2002. These grants are
non-qualified options with a ten year life and are exercisable in cumulative one-third installments
vesting annually beginning on the first anniversary of the date of grant.
Omega Protein
On January 26, 1998, the 1998 Long-Term Incentive Plan of Omega Protein Corporation (the 1998
Incentive Plan) was approved by Omegas Board. The 1998 Incentive Plan provides for the grant of
any or all of the following types of awards: stock options, stock appreciation rights, stock
awards and cash awards. These options generally vest ratably over three years from the date of
grant and expire ten years from the date of grant.
On January 26, 1998, the Non-Management Director Stock Option Plan (the Directors Plan) was
approved by Omegas Board. The Directors Plan provides that the initial Chairman of the Board of
Omega be granted options to
18
purchase 568,200 shares of Common Stock and each other initial non-employee director of Omega will
be granted options to purchase 14,200 shares of Common Stock at a price determined by Omegas
Board.
On June 27, 2000, the 1998 Incentive Plan and the Director Plan were amended and restated in their
entirety and renamed the 2000 Long-Term Incentive Plan (2000 Incentive Plan), and the 2000
Incentive Plan was approved by Omegas stockholders. Under the 2000 Incentive Plan, Omega is
authorized to issue shares of Common Stock pursuant to Awards granted in various forms, including
incentive stock options (intended to qualify under Section 422 of the Internal Revenue Code of
1986, as amended), non-qualified stock options, and other similar stock-based Awards. The
substantive changes from the 1998 Incentive Plan and the Directors Plan in the amendment and
restatement of the 2000 Incentive Plan were (a) the 2000 Incentive Plan allows annual option grant
awards of 10,000 shares to each non-employee Director of Omega and (b) the 2000 Incentive Plan
allows for the aggregate number of option shares available for issuance under the plan to equal 25%
of the number of shares of Omega common stock outstanding at any time with an absolute maximum of
no more than 15 million shares available for awards at any time. Reference is made to Omegas 2000
proxy statement for a complete summary of all the differences among the three plans.
On April 13, 2006 the Omega Protein Board of Directors approved the establishment of the Omega
Protein Corporation 2006 Incentive Plan which was approved by Omegas stockholders and became
effective on June 7, 2006.
Zap.Com
The Zap.Com 1999 Long-Term Incentive Plan (the 1999 Plan), which was approved by stockholders,
allows Zap.Com to provide awards to existing and future officers, employees, consultants and
directors from time to time. The 1999 Plan is intended to promote the long-term financial
interests and growth of Zap.Com by providing employees, officers, directors, and consultants of
Zap.Com with appropriate incentives and rewards to enter into and continue in the employment of, or
relationship with, Zap.Com and to acquire a proprietary interest in the long-term success of
Zap.Com. Under the 1999 Plan, 3,000,000 shares of common stock are available for awards. The 1999
Plan provides for the grant of any or all of the following types of awards: stock options, stock
appreciation rights, stock awards, cash awards, or other rights or interests. Allocations of
awards are made by the Zap.Com Board of Directors at its sole discretion within the provisions of
the 1999 Plan. Stock options granted under the 1999 Plan are non-qualified options with a five
year life and are exercisable in cumulative one-third installments vesting annually beginning on
the first anniversary of the date of grant.
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations
Forward-looking statements in this Form 10-Q, future filings by the Company with the Securities and
Exchange Commission (Commission), the Companys press releases and oral statements by authorized
officers of the Company are intended to be subject to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Investors are cautioned that all forward-looking
statements involve risks and uncertainty, including without limitation those identified from time
to time in press releases and other communications with stockholders by the Company and the filings
made with the Commission by the Company, Omega Protein Corporation (Omega Protein or Omega) and
Zap.Com Corporation (Zap.Com), such as those disclosed under the caption Risk Factors appearing
in Item 1A of this Report. The Company believes that forward-looking statements made by it are
based on reasonable expectations. However, no assurances can be given that actual results will not
differ materially from those contained in such forward-looking statements. The Company assumes no
obligation to update forward-looking statements or to update the reasons actual results could
differ from those projected in the forward-looking statements.
General
Zapata Corporation (Zapata or the Company) was incorporated in Delaware in 1954 and was
reincorporated in Nevada in April 1999. The Companys principal executive offices are at 100
Meridian Centre, Suite 350, Rochester, New York 14618. Zapatas common stock is listed on the New
York Stock Exchange (NYSE) and trades under the symbol ZAP.
19
Zapata is a holding company which currently has one operating company, Omega Protein Corporation
(Omega Protein or Omega), in which the Company had a 58% ownership interest at June 30, 2006.
In December 2005, Zapata completed the sale of its 77% ownership interest in Safety Components
International, Inc. (Safety Components or Safety). Omega Protein trades on the New York Stock
Exchange under the symbol OME and Safety Components trades on the over-the counter electronic
bulletin board (OTCBB) under the symbol SAFY. In addition, Zapata owns 98% of Zap.Com
Corporation (Zap.Com), which is a public shell company and trades on the OTCBB under the symbol
ZPCM.
On December 8, 2005, Zapata announced that the Board of Directors had authorized management to seek
a buyer for its 58% ownership interest in Omega Protein. As of the date of this report, no
agreements or understandings have been entered into by the Company relative to Omega Protein.
There can be no assurance, that a satisfactory transaction involving Omega Protein will emerge, the
timing of any such transaction, if any, or whether the transaction will ultimately enhance Zapata
stockholder value or how that value will be realized. Additionally, there can be no assurance that
we will be able to sell our interest in Omega for an amount in excess of our carrying value. Should
we sell our interest in Omega for an amount less than the carrying value at that time, we would
incur a transaction loss, net of tax consequences. Such losses could be significant and could have
a material adverse impact on our financial position, results from operations and cash flows.
Zapata Corporate
In December 2002, the Board of Directors authorized the Company to purchase up to 4.0 million
shares of its outstanding common stock in the open market or privately negotiated transactions. The
shares may be purchased from time to time as determined by the Company. Any purchased shares would
be placed in treasury and may subsequently be reissued for general corporate purposes. The
repurchases will be made only at such times as are permissible under the federal securities laws.
No time limit has been placed on the duration of the program and no minimum number or value of
shares to be repurchased has been fixed. Zapata reserves the right to discontinue the repurchase
program at any time and there can be no assurance that any repurchases will be made. As of the
date of this report, no shares have been repurchased under this program.
Zapata continues to evaluate strategic opportunities for the use of its capital resources,
including but not limited to the acquisition of other operating businesses, the minority interest
of controlled subsidiaries, funding of start-up proposals and possible stock repurchases. The
Company has not focused and does not intend to focus its acquisition efforts solely on any
particular industry or geographical market. While the Company focuses its attention in the United
States, the Company may investigate acquisition opportunities outside of the United States when
management believes that such opportunities might be attractive. Similarly, the Company does not
yet know the structure of any acquisition. The Company may pay consideration in the form of cash,
securities of the Company or a combination of both. The Company may raise capital through the
issuance of equity or debt and may utilize non-investment grade securities as a part of an
acquisition strategy. Such investments often involve a high degree of risk and may be considered
highly speculative.
As of the date of this report, Zapata is not a party to any agreements related to the acquisition
of an operating business, business combination or for the sale or other transaction related to any
of its subsidiaries. There can be no assurance that any of these possible transactions will occur
or that they will ultimately be advantageous to Zapata or enhance Zapata stockholder value.
Zap.Com
Zap.Com is a public shell company which has no business operations other than complying with its
reporting requirements under the Exchange Act. From time to time, Zap.Com considers acquisitions
that would result in it becoming an operating company. Zap.Com may also consider developing a new
business suitable for its situation.
Omega Protein
Business. Omega is the largest U.S. producer of protein-rich meal and oil derived from marine
sources. Omegas products are produced from menhaden (a herring-like fish found in commercial
quantities), and includes regular grade and value-added specialty fish meals, crude and refined
fish oils and fish solubles.
20
Omega produces and sells a variety of protein and oil products derived from menhaden, a species of
wild herring-like fish found along the Gulf of Mexico and Atlantic coasts. The fish are not
genetically modified or genetically enhanced. Omega processes several
grades of fish meal, as well as fish oil and fish solubles. Omegas fish meal
products are primarily used as a protein ingredient in animal feed for swine, cattle, aquaculture
and household pets. Fish oil is utilized for animal and aquaculture feeds, industrial applications,
additives to human food products and as dietary supplements. Omegas fish solubles are sold
primarily to livestock feed manufacturers, aquaculture feed manufacturers and for use as an organic
fertilizer.
All of Omegas products contain healthy long-chain Omega-3 fatty acids. Omega-3 fatty acids are
commonly referred to as essential fatty acids because the body does not produce them. Instead,
essential fatty acids must be obtained from outside sources, such as food or special supplements.
Long-chain Omega-3s are also commonly referred to as a good fat for their health benefits, as
opposed to the bad fats that create or aggravate health conditions through long-term consumption.
Scientific research suggests that long-chain Omega-3s as part of a balanced diet may provide
significant benefits for health issues such as cardiovascular disease, inflammatory conditions and
other ailments.
Under its patented production process, Omega produces OmegaPure®, a taste-free, odorless
refined fish oil which is the only marine source of long-chain Omega-3s directly affirmed by the
U.S. Food and Drug Administration (FDA) as a food ingredient that is Generally Recognized as Safe
(GRAS). See Company OverviewProducts in Part I Item 1 and 2 of Omegas Form 10-K Annual
Report for the year ended December 31, 2005.
Omega operates through two material subsidiaries: Omega Protein, Inc. and Omega Shipyard, Inc.
Omega Protein, Inc. is Omegas principal operating subsidiary for its menhaden processing business
and is the successor to a business conducted since 1913. Omega Shipyard, Inc. owns a drydock
facility in Moss Point, Mississippi, which is used to provide shoreside maintenance for Omegas
fishing fleet and, subject to outside demand and excess capacity, occasionally for third-party
vessels. Revenues from shipyard work for third-party vessels for the three and six-month periods
ended June 30, 2006 and 2005 were not material. Omega also has a number of other immaterial direct
and indirect subsidiaries.
Prior to 2005, Omega had operated a Mexican subsidiary which had coordinated Omegas fish meal and
oil sales and purchases through a local Mexican sales office. In 2005, Omega discontinued its use
of this Mexican office and consolidated these functions in its Houston, Texas headquarters.
Fishing. During the second quarter of 2006, Omega owned a fleet of 61 fishing vessels and 32
spotter aircraft for use in its fishing operations and also leased additional aircraft where
necessary to facilitate operations. During the 2006 fishing season in the Gulf of Mexico, which
runs from mid-April through October, Omega is operating 30 fishing and carry vessels and 28 spotter
aircraft. The fishing area in the Gulf is generally located along the Gulf Coast, with a
concentration off the Louisiana and Mississippi coasts. The fishing season along the Atlantic coast
begins in early May and usually extends into December. During the 2006 season, Omega is operating
11 fishing vessels and 7 spotter aircraft along the Mid-Atlantic coast, concentrated primarily in
and around Virginia and North Carolina. The remaining fleet of fishing vessels and spotter aircraft
are not routinely operated during the fishing season and are back-up to the active fleet, used for
other transportation purposes, inactive or in the process of refurbishment in Omegas shipyard.
Menhaden usually school in large, tight clusters and are commonly found in warm, shallow waters.
Spotter aircraft locate the schools and direct the fishing vessels to them. The principal fishing
vessels transport two 40-foot purse boats, each carrying several fishermen and one end of a
1,500-foot net. The purse boats encircle the school and capture the fish in the net. The fish are
then pumped from the net into refrigerated holds of the fishing vessel or onto a carry vessel, and
then are unloaded at Omegas processing plants. Carry vessels do not engage in active fishing
but instead carry fish from Omegas offshore fishing vessels to its plants. Utilization of carry
vessels increases the amount of time that certain of Omegas fishing vessels remain offshore
fishing productive waters and therefore increases Omegas fish catch per vessel employed. The
carry vessels have reduced crews and crew expenses and incur less maintenance cost than the actual
fishing vessels.
Omegas principal raw material is menhaden, a species of fish that inhabits coastal and inland
tidal waters in the United States. Menhaden are undesirable for direct human consumption due to
their small size, prominent bones and high oil content. Certain state agencies, as well as
interstate compacts, impose resource depletion restrictions on
21
menhaden pursuant to fisheries management legislation or regulations and may impose additional
legislation or regulations in the future. For example, in August 2005, the Management Board of the
Atlantic States Marine Fisheries Commission (ASMFC) approved an addendum to an existing Fishery
Management Plan. The addendum would have established an annual cap for a five year period
beginning in 2006 on the Companys menhaden landings from the Chesapeake Bay in an amount equal to
the Companys average annual landings over a five year period from 2000 to 2004 (approximately
106,000 metric tons). The Commonwealth of Virginia has declined to adopt the ASMFCs recommended
addendum but has instead put forth its own proposal whereby the Companys Chesapeake Bay menhaden
harvest would be capped for a five year period at its most recent five-year average (2001 to 2005)
of 109,020 metric tons per year. The Virginia proposal would also allow the Company a credit
whereby any under-harvest in a particular year below the 109,020 metric ton cap would be added to
increase the cap for the following year, up to a maximum of 122,740 metric tons per year. The
Company has agreed to support the Commonwealth of Virginias proposal in an effort to move forward
constructively and avoid further contention on this issue. See the Companys 2005 10-K Item 1 and
2. Business and Properties Company OverviewRegulation and Item 5. Other Information.
To date, Omega has not experienced any material adverse impact on its fish catch or results of
operations as a result of these recommended restrictions.
Meal and Oil Processing Plants. Omega operates four meal and oil processing plants, two in
Louisiana, one in Mississippi and one in Virginia, where the menhaden are processed into three
general products types: fish meal, fish oil and fish solubles. Omegas processing plants are
located in coastal areas near Omegas fishing fleet. Annual volume processed varies depending upon
menhaden catch. Each plant maintains a dedicated dock to unload fish, fish processing equipment
and storage facility. The fish are unloaded from the fishing vessels into storage boxes and then
conveyed into steam cookers. The fish are then passed through presses to remove most of the oil and
water. The solid portions of the fish are dried and ground into fish meal. The liquid that is
produced in the cooking and pressing operations contains oil, water, dissolved protein and some
fish solids. This liquid is decanted to remove the water and solids and is put through a
centrifugal oil and water separation process. The separated fish oil is a finished product called
crude oil. The separated water and protein mixture is further processed through evaporators to
recover the soluble protein, which can be sold as a finished product or added to the solid portions
of the fish for processing into fish meal.
Shipyard. Omega owns a 49.4 acre shipyard facility in Moss Point, Mississippi which includes two
dry docks, each with a capacity of 1,300 tons. The shipyard is used for routine maintenance and
vessel refurbishment on Omegas fishing vessels and occasionally for shoreside maintenance services
to third-party vessels if excess capacity exists.
Health and Science Center. In October 2004, Omega completed construction and commenced operation
of a new Health and Science Center that provides 100-metric tons per day fish oil processing
capacity. The new center is located adjacent to Omegas Reedville, Virginia processing plant. The
food-grade facility includes state-of-the-art processing equipment and controls that will allow
Omega to refine, bleach, fractionate and deodorize its menhaden fish oil and has more than tripled
Omegas previous refined fish oil production capacity for food grade oils and industrial and feed
grade oils. The facility also provides Omega with automated packaging and on-site refrigerated
storage capacity and has a lipids analytical laboratory to enhance the development of
Omega-3 oils and food products.
New Technical Center. Omega is in the process of building a new technical center to be located in
Houston, Texas to further develop its OmegaPure® food grade Omega-3 product line. The
technical center will have food science application labs, as well as analytical, sensory and pilot
plant capabilities. The technical center will also have a lipids research lab where Omega plans to
continue to develop new Omega-3 products that have improved functionality and technical
characteristics. The new facility is expected to be completed the latter part of 2006.
Hurricane Damages. In August 2005, Omegas Moss Point, Mississippi fish processing facility and
adjacent shipyard were severely damaged by Hurricane Katrina. In September 2005, Omegas Cameron,
Louisiana and Abbeville, Louisiana fish processing facilities were also severely damaged by
Hurricane Rita. Each of these facilities was non-operational immediately after these weather
events. The Moss Point, Abbeville and Cameron facilities accounted for approximately 16%, 31% and
22%, respectively, of Omegas full year 2004 production tonnage, so as an immediate result of the
two hurricanes, approximately 70% of Omegas operating capacity was impaired and Omegas business,
results of operations and financial condition were materially adversely affected.
22
Operations at the Moss Point and Abbeville fish processing facilities and the shipyard were
re-established in mid-October 2005, but at reduced processing capabilities. These two facilities
were returned to full operational status prior to the beginning of the Gulf fishing season in April
2006. Operations at the Cameron fish processing facility were re-established in June 2006, but at
reduced processing capabilities. The reduced capacity has not had a significant impact on the
processing of the Cameron fish catch since operations were re-established. Omega plans for the
Cameron facility to be at full operational status prior to the end of the 2006 fishing season.
Omega maintains insurance coverage for a variety of these damages, most notably property, inventory
and vessel insurance. The nature and extent of the insurance coverage varies by line of policy and
Omega has recorded insurance recoveries as an account receivable based on the preliminary
discussions with insurers and adjusters. Omega anticipates that further recoveries could be
available, but such additional recoveries will require further analysis and discussions with
Omegas insurance carriers, and the resolution of the lawsuit filed by Omega against its property
insurance carriers described below. Such recoveries, if any, would be recognized in future periods
once they are deemed probable. Omega does not maintain business interruption insurance in any
material amounts due to its high cost and limited availability.
The direct impact of the two hurricanes upon Omega was a loss of physical inventories and physical
damage to the plants. Omega estimated its total hurricane damages at approximately $28.0 million,
of which approximately $12.0 million is expected to be recovered under insurance policies ($4.0
million of which has been received as of June 30, 2006). Therefore, Omega has recognized a $16.2
million loss as of June 30, 2006 due to estimated damages in excess of insurance recoveries. Of
the damage estimate, approximately $2.5 million was related to damaged fish meal inventory and
approximately $13.0 million was related to write-offs of inventory costs that had been allocated to
future production that did not occur. Omega did not maintain business interruption insurance for
these types of deferred inventory costs due to its high cost and limited availability. During the
second quarter 2006, Omega salvaged additional fish meal that was previously recognized as a loss
from natural disaster of approximately $610,000. This meal was sold during the second quarter 2006
which resulted in Omega recognizing revenue without cost of revenues as the related costs were
recorded as a loss in the third quarter 2005. The Company
did not maintain business interruption insurance for these types of deferred inventory costs
due to its high costs and limited availability.
See Omegas 2005 10-K Item 8. Financial Statements
and Supplementary Data Note 12 Hurricane Losses for additional information on the components of
the hurricane related losses. A substantial portion of the amounts listed are based upon estimates
and assumptions. Actual amounts, when available, could differ materially from those estimates and
changes to those estimates could have a material effect on Omegas future financial statements.
In order to facilitate the insurance recovery process, on July 28, 2006, Omega filed a lawsuit
against its property insurance carriers, Lexington Insurance Company and RSUI Indemnity Company, in
U.S. District Court for the Western District of Louisiana, alleging breach of contract and bad
faith based on the insurance carriers failure to pay amounts due to Omega under its property
insurance policies for damages sustained from Hurricanes Katrina and Rita in the third quarter of
2005. Omega seeks recovery in a jury trial of all available damages to which it is entitled by
law, legal interest on those damages, the cost of the litigation and any other damages as the court
deems appropriate.
The total damages sought in the lawsuit are in excess of the amount Omega has remaining as a receivable relating
to its initial recorded hurricane claim from its property insurance carriers. Omega believes collection of
the recorded receivable is probable; however, an unfavorable outcome of the proceeding could have a
material impact on Omegas financial position and result of operations.
Not included in the amounts listed are the replacement capital costs of property and equipment,
which did not have any book basis and were destroyed in the hurricanes, and the costs of clean up
incurred subsequent to June 30, 2006.
As of June 30, 2006, Omegas four active processing plants, assuming that no hurricane damages had
occurred, would have had an aggregate annual capacity to process approximately 950,000 tons of
fish. The previously described hurricane damages reduced the annual aggregate processing capacity
to approximately 850,000 tons as of June 30, 2006. Operations at the Cameron fish
processing facility were re-established in June 2006, but at reduced processing capabilities.
Omega plans for the Cameron facility to be at full operational status prior to the end of the 2006
fishing season.
Because of the damages to Omegas Cameron, Louisiana facility caused by Hurricane Rita, Omega began
its 2006 fishing season by operating its full contingent of 30 Gulf of Mexico fishing and carry
vessels out of its two operating facilities in Abbeville, Louisiana and Moss Point, Mississippi.
These activities substantially increased the number of vessels at the Abbeville and Moss Point
plants to a level that Omega had not operated previously. Although these two facilities had
adequate processing capacity, Omegas fishing efforts were diminished because increased unloading
time due to the additional vessels which reduced the number of vessels on the fishing grounds
during the
23
most optimal fishing times. During June 2006, 10 vessels were shifted to the Cameron facility when
it became operational.
Distribution System. Omegas distribution system of warehouses, tank storage facilities, vessel
loading facilities, trucks, barges and railcars allows Omega to service customers throughout the
United States and also foreign locations. Omega owns and leases warehouses and tank storage space
for storage of its products, generally at terminals along the Mississippi River and Tennessee
River. Omega generally contracts with third-party trucking, vessel, barge and railcar companies to
transport its products to and from warehouses and tank storage facilities and directly to its
customers.
Historically, approximately 35% to 40% of Omegas FAQ grade fish meal was sold on a
two-to-twelve-month forward contract basis. The balance of FAQ grade fish meal and other products
was substantially sold on a spot basis through purchase orders. In 2002, Omega began a similar
forward sales program for its specialty grade meals and crude fish oil due to increasing demand for
these products. During 2003, 2004 and 2005, approximately 50%, 43% and 70%, respectively, of
Omegas specialty meals and crude fish oil had been sold on a forward contract basis. Prior to
the beginning of Omegas 2006 fishing season, approximately 64% and 86% of Omegas 2006 forecasted
fish meal and crude fish oil had either been sold or sold forward on a contract basis. The
percentage of fish meal and crude fish oil sold on a forward contract basis will fluctuate from
year to year based upon perceived market availability.
Omegas annual revenues are highly dependent on both annual fish catch and inventories and, in
addition, inventory is generally carried over from one year to the next year. Omega determines the
level of inventory to be carried over based on prevailing market prices of the products and
anticipated customer usage and demand during the off-season. Thus, production volume does not
necessarily correlate with sales volume in the same year and sales volumes will fluctuate from
quarter to quarter. Omegas fish meal products have a useable life of approximately one year from
date of production. Practically, however Omega attempts to empty its warehouses of the previous
seasons products by the second or third month of the new fishing season. Omegas crude fish oil
products do not lose efficacy unless exposed to oxygen and, therefore, their storage life typically
is longer than that of fish meal.
The following table sets forth Omegas revenues by product (in millions) and the approximate
percentage of total revenues represented thereby, for the indicated periods:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
|
|
2006 |
|
|
2005 |
|
|
2006 |
|
|
2005 |
|
|
|
Revenues |
|
|
Percent |
|
|
Revenues |
|
|
Percent |
|
|
Revenues |
|
|
Percent |
|
|
Revenues |
|
|
Percent |
|
Regular Grade |
|
$ |
4.3 |
|
|
|
12.9 |
% |
|
$ |
5.5 |
|
|
|
20.0 |
% |
|
$ |
8.8 |
|
|
|
14.3 |
% |
|
$ |
9.6 |
|
|
|
18.8 |
% |
Special Select |
|
|
15.7 |
|
|
|
47.1 |
|
|
|
11.9 |
|
|
|
43.3 |
|
|
|
25.8 |
|
|
|
41.9 |
|
|
|
21.8 |
|
|
|
42.5 |
|
Sea-Lac |
|
|
1.9 |
|
|
|
5.7 |
|
|
|
4.2 |
|
|
|
15.3 |
|
|
|
4.5 |
|
|
|
7.3 |
|
|
|
9.1 |
|
|
|
17.7 |
|
Crude Oil |
|
|
8.1 |
|
|
|
24.3 |
|
|
|
4.0 |
|
|
|
14.5 |
|
|
|
16.4 |
|
|
|
26.6 |
|
|
|
7.3 |
|
|
|
14.2 |
|
Refined Oil |
|
|
2.3 |
|
|
|
6.9 |
|
|
|
1.4 |
|
|
|
5.1 |
|
|
|
4.5 |
|
|
|
7.3 |
|
|
|
2.5 |
|
|
|
4.9 |
|
Fish Solubles |
|
|
0.8 |
|
|
|
2.4 |
|
|
|
0.5 |
|
|
|
1.8 |
|
|
|
1.3 |
|
|
|
2.1 |
|
|
|
1.0 |
|
|
|
1.9 |
|
Other |
|
|
0.2 |
|
|
|
0.7 |
|
|
|
0.0 |
|
|
|
0.0 |
|
|
|
0.3 |
|
|
|
0.5 |
|
|
|
0.0 |
|
|
|
0.0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
33.3 |
|
|
|
100.0 |
% |
|
$ |
27.5 |
|
|
|
100.0 |
% |
|
$ |
61.6 |
|
|
|
100.0 |
% |
|
$ |
51.3 |
|
|
|
100.0 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Customers and Marketing. Most of Omegas marine protein products are sold directly to about 600
customers by Omegas agriproducts sales department, while a smaller amount is sold through
independent sales agents. Product inventory was $30.7 million on June 30, 2006 versus $33.4 million
as of June 30, 2005.
Omegas fish meal is sold primarily to domestic feed producers for utilization as a high-protein
ingredient for the swine, aquaculture, dairy and pet food industries. Fish oil sales primarily
involve export markets where the fish oil is used for aquaculture feeds and is refined for use as a
hydrogenated edible oil.
Omegas products are sold both in the U.S. and internationally. International sales consist mainly
of fish oil sales to Norway, Canada, Chile, China, Japan and Mexico. Omegas sales in these foreign
markets are denominated in U.S.
24
dollars and not directly affected by currency fluctuations. Such sales could be adversely
affected by changes in demand resulting from fluctuations in currency exchange rates.
A number of countries in which Omega currently sells products impose various tariffs and duties,
none of which have a significant impact on Omegas foreign sales. Certain of these duties are being
reduced annually for certain countries under the North American Free Trade Agreement and the
Uruguay Round Agreement of the General Agreement on Tariffs and Trade. In all cases, Omegas
products are shipped to its customers either by FOB shipping point or CIF terms, and therefore, the
customer is responsible for any tariffs, duties or other levies imposed on Omegas products sold
into these markets.
During the off season, Omega fills purchase orders from the inventory it has accumulated during the
fishing season or in some cases, by re-selling meal purchased from other suppliers. Prices for
Omegas products tend to be lower during the fishing season when product is more abundant than in
the off season. Throughout the entire year, prices are often significantly influenced by supply and
demand in world markets for competing products, primarily other global sources of fish meal and
oil, and also soybean meal for its fish meal products, and vegetable oils for its fish oil products
when used as an alternative.
Quality Control. Omega believes that maintaining high standards of quality in all aspects of its
manufacturing operations play an important part in its ability to attract and retain customers and
maintain its competitive position. To that end, Omega has adopted strict quality control systems
and procedures designed to test the quality aspects of its products, such as protein content and
digestibility. Omega regularly reviews, updates and modifies these systems and procedures as
appropriate.
Purchases and Sales of Third-Party Meal and Oils. Omega has from time to time purchased fish
meal and fish oil from other domestic and international manufacturers. These purchase and resale
transactions have been ancillary to Omegas base manufacturing and sales business.
Part of Omegas business plan involves expanding its purchase and resale of other manufacturers
fish meal and fish oil products. During 2003, 2004 and 2005, Omegas fish catch and resultant
product inventories were reduced, primarily due to adverse weather conditions, and Omega further
expanded its purchase and resales of other fish meals and oils (primarily Panamanian, Peruvian and
Mexican fish meal and U.S. menhaden oil). Although operating margins from these activities are less
than the margins typically generated from Omegas base domestic production, these operations
provide Omega with a source of fish meal and oil to sell into other
markets, some of which, Omega has not
historically had a presence. During 2003, Omega purchased products totaling approximately 12,500
tons, or approximately 5% of total volume 2003 sales. During 2004, Omega purchased products
totaling approximately 17,800 tons, or approximately 8% of total volume 2004 sales. During 2005,
Omega purchased products totaling approximately 16,600 tons, or approximately 8% of total volume
2005 sales. During the quarter ended March 31, 2006, Omega purchased products totaling
approximately 12,000 tons, the majority of which were sold during the quarter ended June 30, 2006.
Insurance. Omega maintains insurance against physical loss and damage to its assets, coverage
against liabilities to third parties it may incur in the course of its operations, as well as
workers compensation, United States Longshoremens and Harbor Workers Compensation Act and Jones
Act coverage. Assets are insured at replacement cost, market value or assessed earning power.
Omegas limits for liability coverage are statutory or $50 million. The $50 million limit is
comprised of several excess liability policies, which are subject to deductibles, underlying
limits, annual aggregates and exclusions. Omega believes its insurance coverage to be in such form,
against such risks, for such amounts and subject to such deductibles and self-retentions as are
prudent and normal for its operations. Over the last four years, Omega has elected to increase its
deductibles and self-retentions in order to achieve lower insurance premium costs. These higher
deductibles and self-retentions have resulted in greater costs to Omega in the case of Hurricanes
Katrina and Rita and will expose Omega to greater risk of loss if additional future claims occur.
In addition, Omegas cost of insurance for property damage has increased materially and will likely
further increase materially in future years as insurers recoup losses paid and to be paid out in
connection with the Katrina and Rita hurricanes by charging higher premiums. Omega does not
maintain business interruption insurance in any material amount due to its high cost and limited
availability.
Competition.
Omega competes with a smaller domestic privately-owned menhaden fishing company and
with international marine protein and oil producers, including Mexican sardine processors and South
American anchovy
25
processors. In addition, but to a lesser extent, Omegas marine protein and oil business is also
subject to significant competition from producers of vegetable and other animal protein products
and oil products such as Archer Daniels Midland and Cargill. Many of these competitors have
significantly greater financial resources and more extensive and diversified operations than those
of Omega.
Omega competes on price, quality and performance characteristics of its products, such as protein
level and amino acid profile in the case of fish meal. The principal competition for Omegas fish
meal and fish solubles is from other global production of marine proteins as well as other protein
sources such as soybean meal and other vegetable or animal protein products. Omega believes,
however, that these other non-marine sources are not complete substitutes because fish meal offers
nutritional values not contained in such other sources. Other globally produced fish oils provide
the primary market competition for Omegas fish oil, as well as soybean and rapeseed oil, from time
to time.
Fish meal prices have historically borne a relationship to prevailing soybean meal prices (more
weakly correlated in recent years), while prices for fish oil are generally influenced by prices
for vegetable fats and oils, such as rape and palm oils. Thus, the prices for Omegas products are
established by worldwide supply and demand relationships over which Omega has no control and tend
to fluctuate significantly over the course of a year and from year to year.
Omega from time to time considers potential transactions including, but not limited to, enhancement
of physical facilities to improve production capabilities and the acquisition of other businesses.
Certain of the potential transactions reviewed by Omega would, if completed, result in its entering
new lines of business (generally including certain businesses to which Omega sells its products
such as pet food manufacturers, aquaculture feed manufacturers, fertilizer companies and organic
foods distributors), although historically, reviewed opportunities have been generally related in
some manner to Omegas existing operations or which would have added new protein products to
Omegas product lines. Although Omega does not, as of the date hereof, have any commitment with
respect to a material acquisition, it could enter into such agreement in the future.
Omega carries insurance for certain losses relating to its vessels and Jones Act liability for
employees aboard its vessels (collectively, Vessel Claims Insurance). The typical Vessel Claims
Insurance policy contains an annual aggregate deductible (AAD) for which Omega remains
responsible, while the insurance carrier is responsible for all applicable amounts which exceed the
AAD. It is Omegas policy to accrue current amounts due and record amounts paid out on each claim.
Once payments exceed the AAD, Omega records an insurance receivable for a given policy year.
Seasonal and Quarterly Results. Omegas menhaden harvesting and processing business is seasonal in
nature. Omega generally has higher sales during the menhaden harvesting season (which includes the
second and third quarter of each fiscal year) due to increased product availability, but prices
during the fishing season tend to be lower than during the off-season. As a result, Omegas
quarterly operating results have fluctuated in the past and may fluctuate in the future. In
addition, from time to time Omega defers sales of inventory based on worldwide prices for competing
products that affect prices for Omegas products which may affect comparable period comparisons.
Safety Components
Safety Components International, Inc. (Safety Components or Safety) is an independent supplier
of automotive airbag fabric and cushions and technical fabrics with operations in North America and
Europe. Zapata originally purchased its majority interest in Safety in 2003 and accounted for the
transaction under the purchase method of accounting. In the third quarter of 2005, Zapatas Board
of Directors approved a plan to pursue a sale of all of the Companys shares of Safety common
stock. Based on this approval, the Company determined that this subsidiary substantially met the
criteria to report the pending sale as Assets Held for Sale and the subsidiary as Discontinued
Operations in accordance with accounting rules. As used throughout this document, all amounts and
disclosures related to Safety pertain to Discontinued Operations. Zapata closed on the sale of
Safety in December 2005.
26
Consolidated Results of Operations
The following tables summarize Zapatas consolidating results of operations (in thousands).
Certain reclassifications of prior information have been made to conform to the current
presentation.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Zapata |
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, 2006 |
|
Corporate |
|
|
Omega Protein |
|
|
Zap.com |
|
|
Consolidated |
|
Revenues |
|
$ |
|
|
|
$ |
33,338 |
|
|
$ |
|
|
|
$ |
33,338 |
|
Cost of revenues |
|
|
|
|
|
|
28,002 |
|
|
|
|
|
|
|
28,002 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
|
|
|
|
5,336 |
|
|
|
|
|
|
|
5,336 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expense: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative |
|
|
1,964 |
|
|
|
3,670 |
|
|
|
44 |
|
|
|
5,678 |
|
Loss resulting from natural disaster, net |
|
|
|
|
|
|
193 |
|
|
|
|
|
|
|
193 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating (loss) income |
|
|
(1,964 |
) |
|
|
1,473 |
|
|
|
(44 |
) |
|
|
(535 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expense) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income |
|
|
896 |
|
|
|
175 |
|
|
|
21 |
|
|
|
1,092 |
|
Interest expense |
|
|
|
|
|
|
(528 |
) |
|
|
|
|
|
|
(528 |
) |
Other, net |
|
|
190 |
|
|
|
(104 |
) |
|
|
|
|
|
|
86 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,086 |
|
|
|
(457 |
) |
|
|
21 |
|
|
|
650 |
|
(Loss) income before income taxes and
minority interest |
|
|
(878 |
) |
|
|
1,016 |
|
|
|
(23 |
) |
|
|
115 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefit (provision) for income taxes |
|
|
177 |
|
|
|
(386 |
) |
|
|
|
|
|
|
(209 |
) |
Minority interest in net loss (income) of
consolidated subsidiaries(2) |
|
|
|
|
|
|
(266 |
) |
|
|
1 |
|
|
|
(265 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income to common stockholders |
|
$ |
(701 |
) |
|
$ |
364 |
|
|
$ |
(22 |
) |
|
$ |
(359 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted loss per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
(0.02 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Zapata |
|
|
Omega |
|
|
|
|
|
|
Discontinued |
|
|
|
|
Three Months Ended June 30, 2005 |
|
Corporate |
|
|
Protein |
|
|
Zap.com |
|
|
Operations(1) |
|
|
Consolidated |
|
Revenues |
|
$ |
|
|
|
$ |
27,510 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
27,510 |
|
Cost of revenues |
|
|
|
|
|
|
23,693 |
|
|
|
|
|
|
|
|
|
|
|
23,693 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
|
|
|
|
3,817 |
|
|
|
|
|
|
|
|
|
|
|
3,817 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expense: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative |
|
|
1,299 |
|
|
|
3,053 |
|
|
|
35 |
|
|
|
|
|
|
|
4,387 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating (loss) income |
|
|
(1,299 |
) |
|
|
764 |
|
|
|
(35 |
) |
|
|
|
|
|
|
(570 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expense) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income |
|
|
186 |
|
|
|
190 |
|
|
|
12 |
|
|
|
|
|
|
|
388 |
|
Interest expense |
|
|
|
|
|
|
(242 |
) |
|
|
|
|
|
|
|
|
|
|
(242 |
) |
Other, net |
|
|
17 |
|
|
|
230 |
|
|
|
|
|
|
|
|
|
|
|
247 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
203 |
|
|
|
178 |
|
|
|
12 |
|
|
|
|
|
|
|
393 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income before income taxes
and minority interest |
|
|
(1,096 |
) |
|
|
942 |
|
|
|
(23 |
) |
|
|
|
|
|
|
(177 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefit (provision) for income taxes |
|
|
255 |
|
|
|
(283 |
) |
|
|
|
|
|
|
|
|
|
|
(28 |
) |
Minority interest in net income of
consolidated
subsidiaries(2) |
|
|
|
|
|
|
(276 |
) |
|
|
|
|
|
|
|
|
|
|
(276 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income from continuing
operations |
|
|
(841 |
) |
|
|
383 |
|
|
|
(23 |
) |
|
|
|
|
|
|
(481 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discontinued operations: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before taxes and minority
interest (including loss on
disposal) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,639 |
|
|
|
2,639 |
|
Provision for income taxes |
|
|
(401 |
) |
|
|
|
|
|
|
|
|
|
|
(868 |
) |
|
|
(1,269 |
) |
Minority interest (2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(425 |
) |
|
|
(425 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income from discontinued
operations |
|
|
(401 |
) |
|
|
|
|
|
|
|
|
|
|
1,346 |
|
|
|
945 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income to common
stockholders |
|
$ |
(1,242 |
) |
|
$ |
383 |
|
|
$ |
(23 |
) |
|
$ |
1,346 |
|
|
$ |
464 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted income per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
0.02 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
28
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Zapata |
|
|
|
|
|
|
|
|
|
|
Six Months Ended June 30, 2006 |
|
Corporate |
|
|
Omega Protein |
|
|
Zap.Com |
|
|
Consolidated |
|
Revenues |
|
$ |
|
|
|
$ |
61,641 |
|
|
$ |
|
|
|
$ |
61,641 |
|
Cost of revenues |
|
|
|
|
|
|
49,313 |
|
|
|
|
|
|
|
49,313 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
|
|
|
|
12,328 |
|
|
|
|
|
|
|
12,328 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expense: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative |
|
|
3,453 |
|
|
|
7,006 |
|
|
|
74 |
|
|
|
10,533 |
|
Loss resulting from natural disaster, net |
|
|
|
|
|
|
433 |
|
|
|
|
|
|
|
433 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating (loss) income |
|
|
(3,453 |
) |
|
|
4,889 |
|
|
|
(74 |
) |
|
|
1,362 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expense) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income |
|
|
1,712 |
|
|
|
407 |
|
|
|
40 |
|
|
|
2,159 |
|
Interest expense |
|
|
|
|
|
|
(1,052 |
) |
|
|
|
|
|
|
(1,052 |
) |
Other, net |
|
|
194 |
|
|
|
(126 |
) |
|
|
|
|
|
|
68 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,906 |
|
|
|
(771 |
) |
|
|
40 |
|
|
|
1,175 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income before income taxes and
minority interest |
|
|
(1,547 |
) |
|
|
4,118 |
|
|
|
(34 |
) |
|
|
2,537 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income taxes |
|
|
(120 |
) |
|
|
(962 |
) |
|
|
|
|
|
|
(1,082 |
) |
Minority interest in net (income) loss of
consolidated subsidiaries(2) |
|
|
|
|
|
|
(1,329 |
) |
|
|
1 |
|
|
|
(1,328 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income to common stockholders |
|
$ |
(1,667 |
) |
|
$ |
1,827 |
|
|
$ |
(33 |
) |
|
$ |
127 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted income per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
0.01 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
29
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Zapata |
|
|
Omega |
|
|
|
|
|
|
Discontinued |
|
|
|
|
|
|
Corporate |
|
|
Protein |
|
|
Zap.com |
|
|
Operations(1) |
|
|
Consolidated |
|
Six Months Ended June 30, 2005 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues |
|
$ |
|
|
|
$ |
51,341 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
51,341 |
|
Cost of revenues |
|
|
|
|
|
|
44,468 |
|
|
|
|
|
|
|
|
|
|
|
44,468 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
|
|
|
|
6,873 |
|
|
|
|
|
|
|
|
|
|
|
6,873 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expense: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative |
|
|
2,933 |
|
|
|
5,831 |
|
|
|
65 |
|
|
|
|
|
|
|
8,829 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating (loss) income |
|
|
(2,933 |
) |
|
|
1,042 |
|
|
|
(65 |
) |
|
|
|
|
|
|
(1,956 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other income (expense) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income |
|
|
346 |
|
|
|
333 |
|
|
|
22 |
|
|
|
|
|
|
|
701 |
|
Interest expense |
|
|
|
|
|
|
(508 |
) |
|
|
|
|
|
|
|
|
|
|
(508 |
) |
Other, net |
|
|
17 |
|
|
|
191 |
|
|
|
|
|
|
|
|
|
|
|
208 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
363 |
|
|
|
16 |
|
|
|
22 |
|
|
|
|
|
|
|
401 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income before income taxes
and minority interest |
|
|
(2,570 |
) |
|
|
1,058 |
|
|
|
(43 |
) |
|
|
|
|
|
|
(1,555 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefit (provision) for income taxes |
|
|
695 |
|
|
|
(292 |
) |
|
|
|
|
|
|
|
|
|
|
403 |
|
Minority interest in net income of
consolidated
subsidiaries(2) |
|
|
|
|
|
|
(319 |
) |
|
|
|
|
|
|
|
|
|
|
(319 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) income from continuing
operations |
|
|
(1,875 |
) |
|
|
447 |
|
|
|
(43 |
) |
|
|
|
|
|
|
(1,471 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Discontinued operations: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before taxes and minority
interest (including loss on
disposal) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,716 |
|
|
|
5,716 |
|
Provision for income taxes |
|
|
(978 |
) |
|
|
|
|
|
|
|
|
|
|
(1,879 |
) |
|
|
(2,857 |
) |
Minority interest (2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(846 |
) |
|
|
(846 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income from discontinued
operations |
|
|
(978 |
) |
|
|
|
|
|
|
|
|
|
|
2,991 |
|
|
|
2,013 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income to common
stockholders |
|
$ |
(2,853 |
) |
|
$ |
447 |
|
|
$ |
(43 |
) |
|
$ |
2,991 |
|
|
$ |
542 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted income per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
0.03 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Results of operations related to Safety Components have been disclosed within
discontinued operations in accordance with SFAS No. 144. Due to the sale of Safety in December
2005, Safetys results of operations are excluded from Zapatas consolidated results for periods
subsequent to the date of sale. |
|
(2) |
|
Minority interest represents Zapatas minority stockholders interest in the net
income or loss of each segment. |
For more information concerning segments, see Note 14 to the Companys Consolidated Financial
Statements included in Item 1 of this Report.
30
Three Months Ended June 30, 2006 and 2005
Zapata reported a consolidated net loss of $359,000 or $.02 per diluted share on consolidated
revenues of $33.3 million for the three months ended June 30, 2006 as compared to consolidated net
income of $464,000 or $0.02 per diluted share on consolidated revenues of $27.5 million for the
three months ended June 30, 2005. On a consolidated basis, the change from the recognition of net
income to net loss resulted primarily from the lack of consolidation of Safety Components during
the three months ended June 30, 2006 as compared to the same period of the prior year. Safetys
operating results have not been consolidated since the completion of the sale.
The following is a more detailed discussion of Zapatas consolidated operating results:
Revenues from continuing operations. Consolidated revenues increased $5.8 million from $27.5
million for the three months ended June 30, 2005 to $33.3 million for the three months ended June
30, 2006. This increase was attributable to increased revenues at Omega Protein primarily
resulting from an 85% increase in sales volumes of fish oil, partially offset by a 7% decline in
fish meal sales volumes. Additionally, Omega experienced a 11% and 4% increase in sales prices of
fish meal and fish oil, respectively. Omega experienced a $2.7 million increase in revenues due to
increased sales prices and a $3.2 million increase in revenues due to sales volumes of fish meal
and fish oil.
Cost of revenues from continuing operations. Zapatas consolidated cost of revenues, including
depreciation and amortization, for the three months ended June 30, 2006 was $28.0 million, a $4.3
million increase from $23.7 million for the comparable quarter of the prior year. This increase
resulted from an increase at Omega Protein. Omegas cost of revenues as a percentage of revenues
decreased 2% for the quarter ended June 30, 2006. The decrease in cost of revenues as a percentage
of revenues was due to higher sales prices for the current quarter, partially offset by increased
costs and the sale of salvaged fish meal that resulted in Omega recognizing revenue without cost of
revenues as the related costs were recorded as a loss in the third quarter of 2005.
Selling, general and administrative from continuing operations. Consolidated selling, general, and
administrative expenses increased $1.3 million from $4.4 million for the three months ended June
30, 2005 to $5.7 million for the three months ended June 30, 2006. This increase was attributable
to increased selling, general and administrative expenses at Omega Protein of $617,000 and at
Zapata Corporate of $665,000. Omegas increase was attributable primarily to increased consulting
expenditures relating to its governmental relations program and costs incurred relocating the
administrative offices from Hammond, Louisiana to Houston, Texas. Zapata Corporates increase was
primarily attributable to the recognition of $831,000 in expenses to record liabilities related to
health and medical benefits for Malcolm Glazer and his wife under the Companys Senior Executive
Retiree Health Care Benefit Plan, partially offset by decreased consulting expenses after the
scheduled termination of the consulting agreement with Mr. Glazer on April 30, 2006.
Loss resulting from natural disaster. For the quarter ended June 30, 2006, Omega Protein incurred
a loss of $193,000 relating to damages incurred at its Moss Point, Mississippi fish processing
facility and adjacent shipyard from Hurricane Katrina, and damages incurred at its Cameron and
Abbeville, Louisiana fish processing facilities from Hurricane Rita. These costs primarily relate
to clean up costs incurred during the three month period.
Interest income from continuing operations. Consolidated interest income increased $704,000 from
$388,000 for the three months ended June 30, 2005 to $1.1 million for the current quarter. This
increase was primarily related to an increase of $710,000 at Zapata Corporate resulting from higher
interest rates on investment and an increase in cash balance available for investment after selling
its common stock holdings in Safety Components. This increase was partially offset by a decrease
in interest income of $15,000 at Omega Protein primarily due to diminished balances of Omegas cash
and cash equivalents on which interest is earned.
Interest expense from continuing operations. Interest expense increased $286,000 for the quarter
ended June 30, 2006 as compared to the quarter ended June 30, 2005, primarily due to interest
associated with the additional $14.0 million in debt that Omega Protein obtained in October 2005.
Other income, net. Other income decreased $161,000 from $247,000 for the three months ended June
30, 2005 to $86,000 for the current quarter. This decrease was primarily due to an insurance gain
Omega recognized during the quarter ended June 30, 2005.
31
Minority interest from continuing operations. Minority interest from the consolidated statements
of operations represents the minority stockholders interest in the net income of the Companys
subsidiaries (approximately 42% of Omega Protein and approximately 2% of Zap.Com). For the three
months ended June 30, 2006, minority interest was a $265,000 reduction to net income for the
minority interests share of Omega Protein and Zap.Com as compared to $276,000 for the three months
ended June 30, 2005.
Income taxes from continuing operations. The Company recorded a consolidated provision for income
taxes of $209,000 for the three months ended June 30, 2006 as compared to a provision of $28,000
for the comparable period of the prior year. The increase in the consolidated provision was
primarily due to an increase in Omegas effective tax rate. Due to increasing profitability
projections, Omega increased its estimated annual effective tax rate from 19% in the first quarter
of 2006 to 38% as of the second quarter of 2006 resulting in an increased provision for the second
quarter of 2006.
For all periods in which any of the Companys subsidiaries are consolidated for book purposes and
not consolidated for tax purposes, Zapata will recognize a provision or benefit to reflect the
increase or decrease in the difference between the Companys book and tax basis in each subsidiary.
The provision or benefit will be equal to the sum of the Companys tax effected proportionate
share of each subsidiarys net income or loss. For example, during periods where a subsidiary
recognizes net income, the Companys consolidated provision for income taxes will include our
subsidiarys tax provision in addition to a provision for the Companys tax effected proportionate
share of the subsidiarys net income. Accordingly, the Companys effective tax rate for each
period can vary significantly depending on the changes in the underlying difference between the
Companys book and tax basis in its subsidiaries.
Net income from discontinued operations. Pursuant to the Zapata Board of Directors approval of
the plan to sell the Companys shares of Safety Components and the subsequent sale of these shares
to the WLR Recovery Funds, all operating results related to Safety have been reclassified and
included in discontinued operations. For the three months ended June 30, 2005, net income from
discontinued operations was $945,000. Because the sale closed in December of 2005, no amounts
related to discontinued operations were included in the three months ended June 30, 2006.
Six months Ended June 30, 2006 and 2005
Zapata reported consolidated net income of $127,000 or $0.01 per diluted share on consolidated
revenues of $61.6 million for the six months ended June 30, 2006 as compared to consolidated net
income of $542,000 or $0.03 per diluted share on consolidated revenues of $51.3 million for the six
months ended June 30, 2005. On a consolidated basis, the decrease in net income resulted primarily
from the sale of Safety Components. Safetys operating results have not been consolidated since
the completion of the sale.
The following is a more detailed discussion of Zapatas consolidated operating results:
Revenues from continuing operations. Consolidated revenues increased $10.3 million from $51.3
million for the six months ended June 30, 2005 to $61.6 million for the six months ended June 30,
2006. This increase was attributable to increased revenues at Omega Protein, primarily resulting
from a 103% increase in sales volumes of fish oil, partially offset by a 12% decline in fish meal
sales volumes. Additionally, Omega experienced a 11% and 6% increase in sales prices of fish meal
and fish oil, respectively. Omega experienced a $5.0 million increase in revenues due to increased
sales prices and a $5.5 million increase in revenues due to sales volumes of fish meal and fish
oil.
Cost of revenues from continuing operations. Zapatas consolidated cost of revenues, including
depreciation and amortization, for the six months ended June 30, 2006 was $49.3 million, a $4.8
million increase from $44.5 million for the comparable period of the prior year. This increase
resulted from an increase at Omega Protein. Omegas cost of revenues as a percentage of revenues
decreased 7% for the six months ended June 30, 2006. The decrease in cost of revenues as a
percentage of revenues was due to higher sales prices for the current six month period, partially
offset by increased costs.
Selling, general and administrative from continuing operations. Consolidated selling, general, and
administrative expenses increased $1.7 million from $8.8 million for the six months ended June 30,
2005 to $10.5 million for the six months ended June 30, 2006. This increase was attributable to
increased selling, general and administrative expenses at Omega Protein of $1.2 million and at
Zapata Corporate of $520,000. Omegas increase was attributable primarily to increased consulting
expenditures relating to its governmental relations program and costs incurred relocating the
32
administrative offices from Hammond, Louisiana to Houston, Texas. Zapata Corporates increase was
primarily attributable to the recognition of $831,000 in expenses to record liabilities related to
health and medical benefits for Malcolm Glazer and his wife under the Companys Senior Executive
Retiree Health Care Benefit Plan, combined with the recognition of a curtailment loss of $147,000
in the first quarter of 2006 related to the freezing of the Zapata qualified defined benefit
benison plan, partially offset by decreased consulting expenses after the scheduled termination of
the consulting agreement with Mr. Glazer on April 30, 2006, and a compensation charge of $353,000
related to a stock option modification which occurred in the prior period.
Loss resulting from natural disaster. For the six month period ended June 30, 2006, Omega Protein
incurred a loss of $433,000 relating to damages incurred at its Moss Point, Mississippi fish
processing facility and adjacent shipyard from Hurricane Katrina, and damages incurred at its
Cameron and Abbeville, Louisiana fish processing facilities from Hurricane Rita. These costs
primarily relate to clean up costs incurred during the six month period.
Interest income from continuing operations. Consolidated interest income increased $1.5 million
from $701,000 for the six months ended June 30, 2005 to $2.2 million for the current period. This
increase was primarily related to an increase of $1.4 million at Zapata Corporate resulting from
higher interest rates on investment and an increase in cash balance available for investment after
selling its common stock holdings in Safety Components. This increase combined with an increase of
$74,000 at Omega protein primarily due to improved rates of return on Omegas investments.
Interest expense from continuing operations. Interest expense increased $544,000 for the period
ended June 30, 2006 as compared to the period ended June 30, 2005, primarily due to interest
associated with the additional $14.0 million in debt that Omega Protein obtained in October 2005.
Other income, net. Other income decreased $140,000 in the six months ended June 30, 2006 as
compared to the six months ended June 30, 2005. The decrease was primarily due to an insurance gain
Omega recognized during the six months ended June 30, 2005.
Minority interest from continuing operations. Minority interest from the consolidated statements
of operations represents the minority stockholders interest in the net income of the Companys
subsidiaries (approximately 42% of Omega Protein and approximately 2% of Zap.Com). For the six
months ended June 30, 2006, minority interest was a $1.3 million reduction to net income for the
minority interests share of Omega Protein and Zap.Com as compared to $319,000 for the period ended
June 30, 2005.
Income taxes from continuing operations. The Company recorded a consolidated provision for income
taxes of $1.1 million for the six months ended June 30, 2006 as compared to a benefit of $403,000
for the comparable period of the prior year. On a consolidated basis, the change from a benefit to
a provision for income taxes was primarily attributable to an increase in net income recognized at
Omega combined with Omegas increased provision for the second quarter of 2006 and a decrease in
losses recognized by Zapata Corporate.
For all periods in which any of the Companys subsidiaries are consolidated for book purposes and
not consolidated for tax purposes, Zapata will recognize a provision or benefit to reflect the
increase or decrease in the difference between the Companys book and tax basis in each subsidiary.
The provision or benefit will be equal to the sum of the Companys tax effected proportionate
share of each subsidiarys net income or loss. For example, during periods where a subsidiary
recognizes net income, the Companys consolidated provision for income taxes will include our
subsidiarys tax provision in addition to a provision for the Companys tax effected proportionate
share of the subsidiarys net income. Accordingly, the Companys effective tax rate for each
period can vary significantly depending on the changes in the underlying difference between the
Companys book and tax basis in its subsidiaries.
Net income from discontinued operations. Pursuant to the Zapata Board of Directors approval of
the plan to sell the Companys shares of Safety Components and the subsequent sale of these shares
to the WLR Recovery Funds, all operating results related to Safety have been reclassified and
included in discontinued operations. For the six months ended June 30, 2005, net income from
discontinued operations was $2.0 million. Because the sale closed in December of 2005, no amounts
related to discontinued operations were included in the six months ended June 30, 2006.
Liquidity and Capital Resources
33
Zapata, Omega Protein and Zap.Com are separate public companies. Accordingly, the capital resources
and liquidity of Omega Protein and Zap.Com are legally independent of Zapata. The working capital
and other assets of Omega Protein and Zap.Com are dedicated to their respective operations and are
not expected to be readily available for the general corporate purposes of Zapata, except for any
dividends that may be declared and paid to their respective stockholders. Omega Proteins credit
facilities currently prohibit any dividends from being declared or paid with respect to its
outstanding capital stock, including the shares held by Zapata. For all periods presented in this
Report, Zapata has not received any dividends from any of its consolidated subsidiaries.
During the quarter ended June 30, 2006, Zapata recognized selling, general and administrative
expenses of $831,000 to reflect the estimated liability under the Companys Senior Executive
Retiree Health Care Benefit Plan (See Note 7 to the Companys Condensed Consolidated Financial
Statements included in Item 1 of this report). Other than for the recognition of this liability,
as of June 30, 2006, Zapatas consolidated contractual obligations and other commercial commitments
have not changed materially from those set forth in the Companys Annual Report on Form 10-K for
the year ended December 31, 2005.
Zapata Corporate
Because Zapata does not guarantee or otherwise assume the liabilities of Omega Protein or Zap.Com
or have any investment commitments to these majority and formerly-owned subsidiaries, it is useful
to separately review the cash obligations of Zapata exclusive of its majority-owned subsidiaries.
Zapata Corporates liquidity needs are primarily for operating expenses, litigation and insurance
costs. Zapata Corporate may also invest a significant portion of its cash and cash equivalents in
the acquisition of other operating businesses, the minority interest of controlled subsidiaries,
funding of start-up proposals and possible stock repurchases.
During the quarter ended June 30, 2006, Zapata recognized selling, general and administrative
expenses of $831,000 to reflect the estimated liability under the Companys Senior Executive
Retiree Health Care Benefit Plan (See Note 7 to the Companys Condensed Consolidated Financial
Statements included in Item 1 of this report). Other than for the recognition of the liability
under the Zapata Senior Executive Retiree Health Care Benefit Plan discussed above, as of June 30,
2006, Zapata Corporates contractual obligations and other commercial commitments have not changed
materially from those set forth in the Companys Annual Report on Form 10-K for the year ended
December 31, 2005.
Zapata Corporates current source of liquidity is its cash and cash equivalents and the interest
income it earns on these funds. Zapata expects these assets to continue to be a source of
liquidity except to the extent that they may be used to fund any acquisitions of companies, the
minority interest of controlled subsidiaries, or repurchases of Zapata stock. Zapata Corporates
investments consist of U.S. Government agency securities and cash equivalents. As of June 30,
2006, Zapata Corporates cash and cash equivalents were $74.9 million as compared to $75.3 million
as of December 31, 2005. This decline resulted primarily from cash used by Zapata Corporates
operations which exceeded interest income earned during the period.
In addition to its cash, cash equivalents, and interest income, Zapata Corporate has a potential
secondary source of liquidity from dividends declared by Omega Protein or Zap.Com, provided a
consent is obtained from their lenders. Also, the sale of the Companys holdings of common stock
in these subsidiaries could provide another secondary source of liquidity. These holdings
constitute restricted stock under SEC Rule 144 and may only be sold in the public market pursuant
to an effective registration statement under the Securities Act of 1933 and under any required
state securities laws or pursuant to an available exemption. These and other securities law
restrictions could prevent or delay any sale by Zapata of these securities or reduce the amount of
proceeds that might otherwise be realized therefrom. Currently, all of Zapatas equity securities
holdings are eligible for sale under Rule 144. Zapata also has demand and piggyback registration
rights for its Omega Protein and Zap.Com shares. The low trading volumes for Omega Protein and
Zap.Com common stock may make it difficult for Zapata to sell any significant number of shares in
the public market other than pursuant to an underwritten offering.
Zapata management believes that, based on current levels of operations and anticipated growth, cash
flow from operations, together with other available sources of funds, will be adequate to fund its
operational and capital requirements for at least the next twelve months. Depending on the size
and terms of future acquisitions of operating companies or of the minority interest of controlled
subsidiaries, Zapata may raise additional capital through the
34
issuance of equity or debt. There is no assurance, however, that such capital will be available at
the time, in the amounts necessary or with terms satisfactory to Zapata.
Off-Balance Sheet Arrangements
As of June 30, 2006, the Companys off-balance sheet arrangements have not changed materially from
those set forth in the Companys Annual Report on Form 10-K for the year ended December 31, 2005.
Summary of Cash Flows
The following table summarizes Zapatas consolidating cash flow information (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Zapata |
|
|
Omega |
|
|
|
|
|
|
Safety |
|
|
|
|
Six Months Ended June 30, 2006 |
|
Corporate |
|
|
Protein |
|
|
Zap.Com |
|
|
Components |
|
|
Consolidated |
|
Cash (used in) provided by |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating activities |
|
$ |
(541 |
) |
|
$ |
(2,275 |
) |
|
$ |
(20 |
) |
|
$ |
|
|
|
$ |
(2,836 |
) |
Investing activities |
|
|
|
|
|
|
(11,467 |
) |
|
|
|
|
|
|
|
|
|
|
(11,467 |
) |
Financing activities |
|
|
190 |
|
|
|
(925 |
) |
|
|
|
|
|
|
|
|
|
|
(735 |
) |
Effect of exchange rate
changes on cash and cash
equivalents |
|
|
|
|
|
|
(9 |
) |
|
|
|
|
|
|
|
|
|
|
(9 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (decrease) increase in
cash and cash equivalents |
|
$ |
(351 |
) |
|
$ |
(14,676 |
) |
|
$ |
(20 |
) |
|
$ |
|
|
|
$ |
(15,047 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
35
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Zapata |
|
|
Omega |
|
|
|
|
|
|
Safety |
|
|
|
|
Six Months Ended June 30, 2005 |
|
Corporate |
|
|
Protein |
|
|
Zap.Com |
|
|
Components |
|
|
Consolidated |
|
Cash (used in) provided by |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating activities |
|
$ |
(2,049 |
) |
|
$ |
(5,727 |
) |
|
$ |
(39 |
) |
|
$ |
7,461 |
|
|
$ |
(354 |
) |
Investing activities |
|
|
|
|
|
|
(11,280 |
) |
|
|
|
|
|
|
(4,076 |
) |
|
|
(15,356 |
) |
Financing activities |
|
|
23 |
|
|
|
(305 |
) |
|
|
|
|
|
|
(1,363 |
) |
|
|
(1,645 |
) |
Effect of exchange rate changes on cash
and cash equivalents |
|
|
|
|
|
|
12 |
|
|
|
|
|
|
|
(2,425 |
) |
|
|
(2,413 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net decrease in cash and cash equivalents |
|
$ |
(2,026 |
) |
|
$ |
(17,300 |
) |
|
$ |
(39 |
) |
|
$ |
(403 |
) |
|
$ |
(19,768 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by operating activities. Consolidated cash used in operating activities was $2.8
million and $354,000 for the six months ended June 30, 2006 and 2005, respectively. The decrease
in consolidated cash used in operating activities resulted primarily from the change in activities
relating to increased inventory at Omega, combined with ceasing to consolidate Safetys cash flow
information since the completion of the sale in December of 2005.
Net cash used in investing activities. Consolidated cash used in investing activities was $11.5
million and $15.4 million for the six months ended June 30, 2006 and 2005, respectively. The
increase resulted from ceasing to consolidate Safetys cash flow information since the completion
of the sale in December of 2005, combined with a decrease in cash used in investing activities at
Omega Protein. Omegas investing activities for the six months ended June 30, 2006 included the
receipt of $2.0 million in insurance proceeds related to Hurricanes Katrina and Rita, partially
offset by an increase in capital expenditures. In addition to any future capital expenditures
related to the replacement or repair of property and equipment due to Hurricanes Katrina and Rita,
Omega Protein anticipates making approximately $8.0 million in capital expenditures in 2006, which
will be used to refurbish vessels, plant assets and to repair certain equipment.
Net cash used in financing activities. Consolidated cash used in financing activities was $735,000
for the six months ended June 30, 2006 as compared to $1.6 million for the six months ended June
30, 2005. This change resulted primarily from Zapatas sale of Safety Components and ceasing to
consolidate Safetys cash flow information, partially offset by proceeds from stock option
exercises at Omega Protein and Zapata Corporate.
Effect of exchange rate changes. For the six months ended June 30, 2006, cash and cash equivalents
included a $9,000 effect of exchange rate changes as compared to $2.4 million for the six months
ended June 30, 2005. This decrease is a result of ceasing to consolidate Safetys cash flow
information since the sale in December of 2005.
Recent Accounting Pronouncements
In June 2006, the FASB issued FASB Interpretation No. 48, Accounting for Uncertainty in Income
Taxes. The interpretation clarifies the accounting for uncertainty in income taxes recognized in a
companys financial statements in accordance with Statement of Financial Accounting Standards No.
109, Accounting for Income Taxes. Specifically, the pronouncement prescribes a recognition
threshold and a measurement attribute for the financial statement recognition and measurement of a
tax position taken or expected to be taken in a tax return. The interpretation also provides
guidance on the related derecognition, classification, interest and penalties, accounting for
interim periods, disclosure and transition of uncertain tax positions. The interpretation is
effective for fiscal years beginning after December 15, 2006. The Company is currently evaluating
the impact, if any, of this new pronouncement on its consolidated financial statements.
Critical Accounting Policies and Estimates
As of June 30, 2006, the Companys consolidated critical accounting policies and estimates have not
changed materially from those set forth in the Companys Annual Report on Form 10-K for the year
ended December 31, 2005.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
Equity Price Risk. As the Company considers its holdings of Omega Protein and Zap.Com common stock
to be a potential source of secondary liquidity, the Company is subject to equity price risk to the
extent of fluctuations in the
36
market prices and trading volumes of these securities. Fluctuation
in the market price of a security may result from perceived changes in the underlying economic
characteristics of the investee, the relative price of alternative investments and general market
conditions. Furthermore, amounts realized in the sale of a particular security may be affected by
the relative quantity of the security being sold.
Interest Rate Risk. Zapata Corporate and Zap.Com hold investment grade securities which may
include a mix of U.S. Government or Government agency obligations, certificates of deposit, money
market deposits and commercial paper rated A-1 or P-1. In addition, Omega Protein holds
certificates of deposit and commercial quality grade investments rated A-2 P-2 or better with
companies and financial institutions. As the majority of the Companys consolidated investment
grade securities constitute short-term U.S. Government agency securities, the Company does not
believe that the value of these instruments have a material exposure to interest rate risk.
However, changes in interest rates do affect the investment income the Company earns on its cash
equivalents and marketable securities and, therefore, impacts its cash flows and results of
operations. Accordingly, there is inherent roll-over risk for the Companys investment grade
securities as they mature and are renewed at current market rates. Using the Companys
consolidated investment grade security balance of $88.3 million at June 30, 2006 as a hypothetical
constant cash balance, an adverse change of 1% in interest rates would decrease interest income by
approximately $442,000 during a six-month period.
Market Risk. Omega Protein is exposed to minimal market risk associated with interest rate
movements on its borrowings. A one percent increase or decrease in the levels of interest rates on
such borrowings would not result in a material change to the Companys results of operations.
Currency Exchange Rates and Forward Contracts. Although Omega Protein sells products in foreign
countries, all of Omegas revenues are billed and paid for in US dollars. As a result, Omegas
management does not believe that it is exposed to any significant foreign country currency exchange
risk, and Omega does not utilize market risk sensitive instruments to manage its exposure to this
risk.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
The Company maintains disclosure controls and procedures that are designed to ensure that
information required to be disclosed in the reports that the Company files or submits under the
Securities Exchange Act of 1934 (the Exchange Act) is recorded, processed, summarized, and
reported within the time periods specified in the SECs rules and forms, and that such information
is accumulated and communicated to the Companys management, including its Chief Executive Officer
and Chief Financial Officer, as appropriate, to allow timely decisions regarding required
disclosures.
An evaluation was performed under the supervision of the Companys management, including the Chief
Executive Officer (CEO) and Chief Financial Officer (CFO), of the effectiveness of the design and
operation of the Companys disclosure controls and procedures (as defined in the Exchange Act Rules
13a-15(e) and 15d-15(e)) as of the end of the period covered by this report. Based upon this
evaluation as of June 30, 2006, the Chief Executive Officer and Chief Financial Officer concluded
that the Companys disclosure controls and procedures were not effective for the reasons more fully
described below related to the unremediated material weakness in the Companys internal control
over financial reporting identified during the Companys evaluation pursuant to Section 404 of the
Sarbanes-Oxley Act of 2002 as of the year ended December 31, 2005. To address this control
weakness, the Company performed additional analysis and performed other procedures in order to
prepare the unaudited quarterly consolidated financial statements in accordance with generally
accepted accounting principles in the United States of America. Accordingly, management believes
that the consolidated financial statements included in this Quarterly Report on Form 10-Q fairly
present, in all material respects, our financial condition, results of operations and cash flows
for the periods presented.
Managements assessment determined that as of December 31, 2005, the Company did not maintain
effective controls over the application and monitoring of its accounting for income taxes.
Specifically, we did not have controls designed and in place to ensure the accuracy and
completeness of financial information provided to the Company by third party tax advisors used in
accounting for income taxes and the determination of current income taxes payable, deferred income
tax assets and liabilities and the related income tax provision (benefit) and the
review and evaluation of the application of generally accepted accounting principles relating to
accounting for income taxes. This control deficiency resulted in the restatement of the Companys
consolidated financial statements
37
for quarter ended September 30, 2005. Additionally, this control
deficiency could result in a material misstatement of the aforementioned accounts that would result
in a material misstatement to annual or interim financial statements that would not be prevented or
detected. Accordingly, management determined that this control deficiency constituted a material
weakness.
This section of Item 4, Controls and Procedures, should be read in conjunction with Item 9A,
Controls and Procedures, included in the Companys Form 10-K for the year ended December 31,
2005, for additional information on Managements Report on Internal Controls Over Financial
Reporting.
Remediation Plans for Material Weakness in Internal Control over Financial Reporting
Management believes that progress has been made in executing the remediation plans that were
established to address the material weakness in its internal controls surrounding the accounting
for income taxes. As of the date of this filing, the following remedial actions have been
undertaken:
|
|
|
For the first and second quarters of 2006, the Company engaged our outside tax advisors
in robust discussions regarding our quarterly tax provision. These discussions included a
detailed review of the impact of the quarterly provision on the Companys deferred income
tax accounts. This process has and should continue to improve the review and oversight
process relating to the internal controls over the Companys accounting for income taxes. |
|
|
|
|
During the second quarter of 2006, the Company held training sessions on accounting for
income taxes for its entire professional accounting staff. Ongoing training is expected to
improve our knowledge of accounting for income taxes which should enhance our ability to
review and evaluate the tax financial information prepared by our outside tax advisors
which supports the Companys quarterly tax provision. |
As discussed above, Management believes that progress has been made in efforts to remediate this
material weakness during 2006. In making its determination as to the status of the remediation of
this material weakness as of June 30, 2006, the Company has considered all of the factors set forth
above and has concluded that the internal controls surrounding the accounting for income taxes are
effectively designed, however, as a result of the audit adjustments identified as of and for the
nine months ended September 30, 2005, the Company has not yet demonstrated an adequate period of
operating effectiveness with respect to controls over the completeness and accuracy of its income
tax accounting. Accordingly, the Company continues to report this as a material weakness as of
June 30, 2006. In order to remediate this deficiency in internal controls, the Company will
continue its training and education efforts in this area and work closely with our outside tax
advisors so that operating effectiveness can be demonstrated over a period of time that is
sufficient to support the conclusion that the material weakness has been remediated.
The Company will continue to implement enhancements to its internal control over financial
reporting to provide reasonable assurance that errors and control deficiencies in its accounting
for income taxes will not recur. Notwithstanding the foregoing, there can be no assurance that the
Companys disclosure controls and procedures will detect or uncover all failures of persons within
the Company and its consolidated subsidiaries to disclose material information otherwise required
to be set forth in the Companys periodic reports. There are inherent limitations to the
effectiveness of any system of disclosure controls and procedures, including the possibility of
human error and the circumvention or overriding of the controls and procedures. Accordingly, even
effective disclosure controls and procedures can only provide reasonable, not absolute, assurance
of achieving their control objectives.
Internal Control Over Financial Reporting.
Except as otherwise discussed herein, there have been no changes in the Companys internal control
over financial reporting during the most recently completed fiscal quarter that have materially
affected, or are reasonably likely to materially affect, the Companys internal control over
financial reporting.
38
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
None.
Item 1A. Risk Factors
As of June 30, 2006, the Companys risk factors have not changed materially from the
risk factors previously disclosed in the Companys Annual Report on Form 10-K for the
year ended December 31, 2005.
Item 2. Unregistered Sales of Securities and Use of Proceeds
None.
Item 3. Defaults upon Senior Securities
None.
Item 4. Submission of Matters to a Vote of Security Holders
The Company held its Annual Meeting of Stockholders on June 16, 2006. The following are the
results of the votes taken on the various matters presented to the Companys stockholders at the
meeting.
All of the Boards nominees for directors were elected as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
Class II Directors: Term ending 2009 |
|
For |
|
Withhold |
|
No Vote |
Avram A. Glazer |
|
|
16,371,464 |
|
|
|
1,595,390 |
|
|
|
1,215,602 |
|
Warren H. Gfeller |
|
|
16,682,948 |
|
|
|
1,283,906 |
|
|
|
1,215,602 |
|
John R. Halldow |
|
|
16,682,829 |
|
|
|
1,284,025 |
|
|
|
1,215,602 |
|
The proposal to ratify the appointment of PricewaterhouseCoopers LLP as the independent registered
public accounting firm was passed with the following vote:
|
|
|
|
|
|
|
|
|
|
|
|
|
For |
|
Against |
|
Abstain |
|
No Vote |
17,639,825 |
|
|
318,623 |
|
|
|
8,406 |
|
|
|
1,215,602 |
|
The Class III directors, whose terms expire at the 2007 Annual Meeting of Stockholders, are Edward
S. Glazer and Robert V. Leffler, Jr. The Class I directors, whose terms expire at the 2008 Annual
Meeting of Stockholders, are Darcie S. Glazer and Bryan G. Glazer.
Item 5. Other Information
None.
Item 6. Exhibits
(a) Exhibits
|
|
|
31.1
|
|
Certification of CEO Pursuant to Rule 13a-14 or 15d-14 of the Securities Exchange
Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
|
31.2
|
|
Certification of CFO Pursuant to Rule 13a-14 or 15d-14 of the Securities Exchange
Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
|
|
|
32.1
|
|
Certification of CEO Pursuant to 18 U.S.C Section 1350, as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002. |
39
|
|
|
32.2
|
|
Certification of CFO Pursuant to 18 U.S.C Section 1350, as Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002. |
40
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused
this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
ZAPATA CORPORATION
(Registrant) |
|
|
|
|
|
|
|
|
|
Dated: August 8, 2006
|
|
By:
|
|
/s/ Leonard DiSalvo
(Vice President Finance and Chief
|
|
|
|
|
|
|
Financial Officer) |
|
|
41
EX-31.1
Exhibit 31.1
CERTIFICATION PURSUANT TO RULE 13A-14 OR 15D-14 OF THE SECURITIES
EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002
I, Avram A. Glazer, certify that:
|
1. |
|
I have reviewed this quarterly report on Form 10-Q of Zapata Corporation; |
|
|
2. |
|
Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with
respect to the period covered by this report; |
|
|
3. |
|
Based on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods
presented in this report; |
|
|
4. |
|
The registrants other certifying officer(s) and I are responsible for establishing
and maintaining disclosure controls and procedures (as defined in Exchange Act Rules
13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in
Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting or caused such internal
control over financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with
generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrants disclosure controls and
procedures and presented in this report our conclusions about the effectiveness of
the disclosure controls and procedures, as of the end of the period covered by this
report based on such evaluation; and
(d) Disclosed in this report any change in the registrants internal control over
financial reporting that occurred during the registrants most recent fiscal quarter
(the registrants fourth fiscal quarter in the case of an annual report) that has
materially affected, or is reasonably likely to materially affect, the registrants
internal control over financial reporting; and
|
5. |
|
The registrants other certifying officer(s) and I have disclosed, based on our
most recent evaluation of internal control over financial reporting, to the registrants
auditors and the audit committee of the registrants board of directors (or persons
performing the equivalent functions): |
(a) All significant deficiencies and material weaknesses in the design or operation
of internal control over financial reporting which are reasonably likely to
adversely affect the registrants ability to record, process, summarize and report
financial information; and
(b) Any fraud, whether or not material, that involves management or other employees
who have a significant role in the registrants internal control over financial
reporting.
Date: August 8, 2006
|
|
|
|
|
/s/ Avram A. Glazer
Avram A. Glazer
|
|
|
|
|
President and CEO |
|
|
|
|
42
EX-31.2
Exhibit 31.2
CERTIFICATION PURSUANT TO RULE 13A-14 OR 15D-14 OF THE SECURITIES
EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002
I, Leonard DiSalvo, certify that:
|
1. |
|
I have reviewed this quarterly report on Form 10-Q of Zapata Corporation; |
|
|
2. |
|
Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact necessary to make the statements made, in
light of the circumstances under which such statements were made, not misleading with
respect to the period covered by this report; |
|
|
3. |
|
Based on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods
presented in this report; |
|
|
4. |
|
The registrants other certifying officer(s) and I are responsible for establishing
and maintaining disclosure controls and procedures (as defined in Exchange Act Rules
13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in
Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this report is being prepared;
(b) Designed such internal control over financial reporting or caused such internal
control over financial reporting to be designed under our supervision, to provide
reasonable assurance regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in accordance with
generally accepted accounting principles;
(c) Evaluated the effectiveness of the registrants disclosure controls and
procedures and presented in this report our conclusions about the effectiveness of
the disclosure controls and procedures, as of the end of the period covered by this
report based on such evaluation; and
(d) Disclosed in this report any change in the registrants internal control over
financial reporting that occurred during the registrants most recent fiscal quarter
(the registrants fourth fiscal quarter in the case of an annual report) that has
materially affected, or is reasonably likely to materially affect, the registrants
internal control over financial reporting; and
|
5. |
|
The registrants other certifying officer(s) and I have disclosed, based on our
most recent evaluation of internal control over financial reporting, to the registrants
auditors and the audit committee of the registrants board of directors (or persons
performing the equivalent functions): |
(a) All significant deficiencies and material weaknesses in the design or operation
of internal control over financial reporting which are reasonably likely to
adversely affect the registrants ability to record, process, summarize and report
financial information; and
(b) Any fraud, whether or not material, that involves management or other employees
who have a significant role in the registrants internal control over financial
reporting.
Date: August 8, 2006
|
|
|
|
|
|
|
|
|
|
Leonard DiSalvo |
|
|
|
|
Vice President Finance and CFO |
|
|
|
|
43
EX-32.1
Exhibit 32.1
CERTIFICATION OF CEO PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT
TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Zapata Corporation (the Company) on Form 10-Q for the
period ending June 30, 2006 as filed with the Securities and Exchange Commission on the date hereof
(the Report), I, Avram A. Glazer, as Chief Executive Officer of the Company, hereby certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002 to the best of my knowledge, that:
|
(1) |
|
The Report fully complies with the requirements of Section 13(a) of the
Securities Exchange Act of 1934; and |
|
|
(2) |
|
The information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the Company. |
|
|
|
|
|
|
|
|
|
|
Avram A. Glazer
Chairman of the Board, President and Chief Executive Officer
August 8, 2006 |
|
|
|
|
This Certification accompanies this Report pursuant to Section 906 of the Sarbanes-Oxley Act of
2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended.
44
EX-32.2
Exhibit 32.2
CERTIFICATION OF CFO PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Zapata Corporation (the Company) on Form 10-Q for the
period ending June 30, 2006 as filed with the Securities and Exchange Commission on the date hereof
(the Report), I, Leonard DiSalvo, as Chief Financial Officer of the Company, hereby certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002 to the best of my knowledge, that:
|
(1) |
|
The Report fully complies with the requirements of Section 13(a) of the
Securities Exchange Act of 1934; and |
|
|
(2) |
|
The information contained in the Report fairly presents, in all material
respects, the financial condition and result of operations of the Company. |
|
|
|
|
|
/s/ Leonard DiSalvo
Leonard DiSalvo
Vice President Finance and Chief Financial Officer
August 8, 2006
|
|
|
|
|
This Certification accompanies this Report pursuant to Section 906 of the Sarbanes-Oxley Act of
2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended.
45